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Abstract 
The research reported in this thesis focused on three proteinaceous virulence 
factors of the intracellular bacterial pathogen Listeria monocytogenes: listeriolysin O 
(LLO), broad-range phospholipase C (PC-PLC), and phosphatidylinositol-specific 
phospholipase C (PI-PLC). Based on sequence homology of LLO with other cholesterol-
dependent cytolysins (CDC), the protein has four domains of which domain 4 is thought 
to anchor the protein to cholesterol-containing surfaces while domain 3 mediates protein-
protein binding on the membrane and contributes α-helices that convert to two β-strands 
that form the large β-barrel pore. It was previously assumed that the sequential and 
cooperative behaviors of domain 3 in each LLO monomer required D4 to bind to 
cholesterol-enriched membranes. By cloning and expressing a separate protein containing 
domains 1, 2, and 3 (D123) and the isolated domain 4 (D4) of LLO, I could uncouple 
some of the events in its membrane binding and pore-formation. Flow cytometry, used to 
investigate protein binding to vesicles and to red blood cells, showed that D123 had no 
membrane affinity on its own, but became membrane-bound when sub-lytic amounts of 
LLO were added. D123, not membrane-lytic by itself, became hemolytic when trace 
amounts of LLO were present to provide a membrane anchor for D123 proteins. FRET 
and fluorescence correlation spectroscopy were used to show that D123 and LLO formed 
oligomers at nanomolar concentration and could also associate with one another in the 
solution. These results suggest that D4 provides an initial membrane attachment but need 
not be present on all monomers to trigger the cooperative conformational change that 
leads to membrane insertion and pore formation.   
The gene for L. monocytogenes PC-PLC was obtained, expressed in E. coli and 
the product protein purified and characterized. The zinc content of this metalloenzyme 
was analyzed with ICP-MS. The dissociation constants of the three zinc ions proposed as 
necessary for PC-PLC activity ranged from	  0.05	  to	  60	  μM. Enzymatic activities of PC-
PLC were analyzed for various substrates, include long-chain phospholipid in vesicles 
(LUVs, SUVs) and micelles (Triton X-100), and short-chain lipids (diC4PC, diC6PC, 
diC7PC) mono-dispersed in solutions. Key results include the following: (1) the L. 
monocytogenes PC-PLC has an acidic pH optimum (in contrast to other bacterial PC-PLC 
enzymes) consistent with its role in vacuole lysis upon acidification; (2) the preference of 
PC-PLC for longer chain monomeric substrates is not because of a higher kcat but a 
reduced Km suggesting some amount of hydrophobicity is important for substrate binding 
in the active site;  (3) the apparent Kd of PC-PLC for Zn2+ derived from kinetics at pH 6.0 
(1.94 ±	  0.22	  μM)	  is	  lower	  that	  that	  from	  ICP-­‐MC;	  and	  (4)	  PC-PLC enzymatic activity is 
not enhanced by added LLO	   that	  generates	  pores	   in	  vesicles	  (likewise,	  PC-­‐PLC	  does	  not	  affect the membrane lytic activity of LLO) indicating no synergism between the two 
virulence factors. These results should aid in understanding the function of PC-PLC in L. 
monocytogenes pathogenicity. 
The L. monocytogenes PI-PLC and a variant with reduced catalytic activity were 
expressed and are currently used in a collaborative project with the Portnoy laboratory at 
the University of California at Berkeley.  
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Chapter 1    Introduction 
1.1 Listeria monocytogenes       
     Listeria monocytogenes is a Gram-positive, facultative, food-borne, intracellular 
bacterial pathogen of human and animals. It is the causative agent of listeriosis, a severe 
illness that affects immunocompromised individuals and pregnant women [Vazquez-
Boland et al., 2001].  
     L. monocytogenes can invade a wide variety of cells through phagocytosis or 
pathogen-induced endocytosis. Upon initial entry, bacteria are immediately trapped in 
single-membrane vacuoles. Under normal circumstances, the vacuole will progressively 
acidify and eventually fuse with a host cell lysosome, where the foreign contents will be 
digested. L. monocytogenes is unable to replicate in the phagosomal compartment of 
mammalian cells but is exquisitely adapted to life in the host cell cytosol. The bacteria 
have evolved to escape from the vesicles after acidification and prior to digestion. 
Following phagosomal escape, L. monocytogenes cells end up in the host cell cytosol, 
where they proliferate. The bacteria can reach high numbers (>200 bacteria) in the 
cytosol without causing host cell toxicity [Schnupf and Portnoy, 2007]. These cytosolic 
bacteria hijack the host cell’s machinery for actin polymerization and use actin-based 
motility to spread from cell to cell without entering the extracellular milieu, causing 
infections in more distant tissues [Figure 1.1; Tilney and Portnoy, 1989; Cameron et al., 
1999; Cossart and Bierne, 2001]. 
     The pathogenicity of L. monocytogenes is associated with the production of virulence 
factors, most of which are proteins that are either surface-associated or secreted into the 
growth medium [Cossart and Bierne, 2001; Vazquez-Boland et al., 2001; Cabanes et al., 
	   2	  
2002]. The genes encoding the major virulence factors of L. monocytogenes are clustered 
mainly in two distinct chromosomal loci: the virulence locus that comprises the hly gene 
encoding listeriolysin O (LLO), controlled by the pleiotropic regulatory activator, PrfA; 
and the inlAB locus, also partially controlled by PrfA [Milohanic et al., 2003].  
 
             
    
1.1.1 Vacuolar escape of L. monocytogenes 
     One remarkable feature of L. monocytogenes pathogenesis is its prompt escape from 
two distinct vacuoles: (1) the single-membrane vacuoles that surround the bacteria after 
initial host cell invasion, and (2) the double-membrane vacuoles resulting from cell-to-
cell spread. Failure in vacuolar escape results in an abortive and avirulent infection 
[Cossart et al., 1989]. Multiple virulence factors of L. monocytogenes have been 
Figure 1.1 Major events in the life cycle of the intracellular pathogen L. 
monocytogenes [picture was adapted from Tilney and Portnoy, 1989]. 
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identified to be responsible for mediating phagosomal escape. Three of them have been 
studied in my work: listeriolysin O (LLO), encoded by the hly gene, is a pore-forming 
cytolysin [Geoffroy et al., 1987; Mengaud et al., 1988]; a phosphatidylinositol-specific 
phospholipase C (PI-PLC) [Camilli et al., 1991; Leimeister-Wachter et al., 1991; 
Mengaud et al., 1991], and a broad-range phospholipase C (PC-PLC) [Vazquez-Boland et 
al., 1992; Smith et al., 1995], encoded by the plcA and plcB genes. 
  
1.2 Listeriolysin O (LLO) 
     Listeriolysin O (LLO) is essential to promote the escape of L. monocytogenes from a 
phagosome into the cytoplasm [Portnoy et al., 1988; Gedde et al., 2000; Dancz et al., 
2002]. In the absence of LLO, L. monocytogenes bacteria remain trapped in the acidified 
phagosome in most cell types and are unable to replicate [Portnoy et al., 1988; 
Beauregard, K., 1997; Henry, et al., 2006]. Similarly, neutralizing antibody to LLO 
inhibits phagosomal escape of wild-type L. monocytogenes [Edelson and Unanue, et al., 
2001]. In addition, LLO is sufficient to allow escape of Bacillus subtilis and E. coli from 
phagocytic vacuoles [Bielecki et al., 1990]. 
     LLO also mediates membrane disruption of the secondary vacuole after cell-to-cell 
spread. When LLO transcription was put under an IPTG-inducible promoter, the size of 
the plaque resulting from cell-to-cell spread was found to correlate with IPTG in a dose-
dependent fashion [Dancz et al., 2002].  
     In a murine model of infection, LLO activity is absolutely required. In L. 
monocytogenes producing inactive LLO, virulence was diminished more than five logs in 
the mouse model of listeriosis [Portnoy et al., 1988].  
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1.2.1 LLO is a pore-forming virulence factor 
     LLO is a member of the family of cholesterol-dependent cytolysins (CDCs). CDCs are 
β-barrel pore-forming toxins that require high concentrations of cholesterol to insert into 
cell membranes [reviewed in Tweten et al., 2001; Bayley, 1997; Heuck, 2010]. Other 
examples include streptolysin O, perfringolysin O (PFO), and pneumolysin. LLO is the 
only CDC that is made by an intracellular pathogen; it also has a pronounced acidic pH 
optimum for insertion and membrane rupture [Glomski et al., 2002].  
     Early work of Jones and Portnoy [Jones and Portnoy, 1994] showed that expression of 
the pfo gene (encoding PFO) under phly promoter control, in an hly-negative mutant of L. 
monocytogenes, restored hemolytic activity and promoted partial phagosomal escape 
(~50%) in the mouse macrophage-like J774 cell line. However, L. monocytogenes 
secreting PFO killed the host cell after entry into the cytosol and therefore did not restore 
virulence. The cytotoxicity of PFO is due in part to the lack of a PEST-like sequence in 
PFO, which targets LLO for phosphorylation and/or degradation in the cytosol [Decatur 
and Portnoy, 2000]. More importantly, PFO does not have the pronounced acidic pH 
optimum like LLO [Portnoy et al, 1992], which could be a way to compartmentalize LLO 
activity in the vacuoles and then allow release as the vacuoles become acidified. 
     Crystal structures of the soluble monomers have been solved for three of the CDCs: 
perfringolysin O (PFO) from Clostridium perfringens [Rossjohn et al., 1997], 
intermedilysin (ILY) from Streptococcus intermedius [Bourdeau et al., 2009], and 
anthrolysin O (ALO) from Bacillus anthracis [Polekhina et al., 2005] revealing a four 
domain structure, Domain 1 to Domain 4 (D4). Based on the degree of sequence identity 
(>28%) and similarity (>45%) among CDC members, the three-dimensional structure and 
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modes of action are assumed to be similar [Heuck et al., 2000]. The structure of LLO was 
estimated via SWISS-MODEL [Arnold et al., 2006] based on homology with 
perfringolysin (Figure 1.4) and is shown in Figure 1.2.  
         
 
1.2.2 Cholesterol-dependent cytolysins (CDC)       
      CDCs are secreted by a large number of pathogenic Gram-positive bacteria [Bayley, 
1997]. Generally, these toxins are produced as water-soluble proteins that specifically 
recognize and bind cholesterol in the target mammalian membranes. On the target 
membrane, CDC monomers aggregate and oligomerize, forming arc- and ring-like 
architectures. With a concerted conformational change of each monomer, CDC oligomers 
penetrate the membrane bilayer, forming a giant β-barrel pore [Giddings et al., 2005; 
Olofsson et al., 1993; Czajkowsky et al., 2004; Dang et al., 2005; Tilley et al., 2005]. The 
dimensions of the pore range up to nearly 300 Å [Heuck et al., 2010]. 
Figure 1.2 Model structure of LLO based on 
sequence homology of PFO. Domains 1 to 4 are 
labeled as D1 (yellow), D2 (blue), D3 (green), 
and D4 (red). The undecapeptide and the Thr490-
Leu491 are in purple. The two residues Thr490-
Leu491 critical for pH-sensitivity are represented 
in sticks. 
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     PFO is the prototypical CDC, from which most of the general mechanism of pore-
formation for the CDC has been revealed. Specifically, the C-terminal domain 4 (D4) of 
PFO encounters the membrane first (Figure 1.3, step I). The binding of D4 triggers the 
structural rearrangements required to initiate the oligomerization of PFO monomers and 
formation of a prepore complex on the membrane surface (step II). Pore formation 
commences when two amphipathic β-hairpins from each PFO molecule insert and span 
the membrane (step III). The concerted insertion of two transmembrane β-hairpins from 
up to 50 monomers then creates the large transmembrane β-barrel that penetrates the 
membrane. While the formation of a prepore complex has been demonstrated, it is still 
controversial whether incomplete toxin rings also undergo the structural changes of 
prepore-to-pore transition [Gilbert, 2005]. 
 
Figure 1.3 Model of the pore-forming mechanism of CDCs on a target membrane. 
Defined domains of CDCs are numbered. The pore formation occurs in three steps. Step 
I, membrane binding; step II, oligomerization; step III, membrane penetration. The 
membrane bilayer is depicted with cholesterol molecules intercalated between the 
phospholipid constituents. 
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1.2.3 D4 and membrane binding 
     From the sequence similarity between LLO and other CDCs (as shown in sequence 
alignment of LLO and PFO in Figure 1.4), it is notable that conservation is generally 
higher in the D4 domain than in the other portions of the molecule. The sequence identity 
between LLO and PFO is 64% in the D4 but only 38% in the rest of the molecule (42% 
for the whole sequence) [Kayal and Charbit, 2006]. This is understandable since domain 
4 is the region in all CDCs that mediates the cholesterol-dependent membrane binding, 
which is the essential character of CDC family proteins that they are named after. 
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Figure 1.4 Amino acid sequence alignment of LLO with PFO, produced by online 
program T-coffee [Di Tommaso et al., 2011]. “*”: identical; “:”: conserved 
substitutions; “.”: semi-conserved substitutions. The sequence of the PEST-like 
motif is highlighted in blue and that of domain 4 (D4) is in yellow. 
LLO 
PFO 
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     Cytolysis starts when the C-terminal D4 first contacts the target membrane. Domain 4 
has a β-sandwich structure with an undecapeptide and three other short loops at the tip 
[Figure 1.2]. These loops do not penetrate deeply into the membrane and do not directly 
participate in the architecture of the transmembrane pore, rather they help in the initial 
anchoring of a monomer on the membrane. It has been shown that D4 is oriented 
perpendicular to the membrane interface and the bulk of it is surrounded by the aqueous 
milieu, even in the oligomeric state [Ramachandran et al., 2002; Soltani et al., 2007a]. 
One of these loops, an 11 amino acid-residue sequence, ECTGLAWEWWR also known 
as the Trp-rich loop, is highly conserved among the CDCs [Alouf et al., 2005; purple 
loop in Figure 1.2]. Modifications in this conserved undecapeptide typically inhibit the 
hemolytic activity of the toxin by blocking the conformational changes that are required 
to allosterically trigger the insertion of the transmembrane β-barrel [Michel et al., 1990; 
Ramachandran et al., 2004; Soltani et al., 2007b]. The correlation between this highly 
conserved amino acid sequence and the absolute cholesterol dependence led researchers 
to hypothesize that this undecapeptide represented the cholesterol-binding site for the 
CDCs [Rossjohn et al., 2007]. However, it has been shown that cholesterol recognition 
and toxin binding are mediated by three other loops, while the insertion of the 
undecapeptide may be coupled to the insertion of the transmembrane β-barrel [Soltani et 
al., 2007b]. More specifically, two residues Thr490-Leu491 in D4 have been identified as 
essential for specifically recognizing cholesterol in the membrane and initiating the 
cholesterol-dependent interaction of CDCs with membranes [Farranda et al., 2010]. 
     There is also an important Cys residue in the undecapeptide whose modification 
inhibits pore-forming activity. Previously, the CDCs were designated as thiol-activated 
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toxins since CDC activity could be inhibited by oxidation or thiol-reacting compounds 
and reactivated by thiol-reducing agents [Smyth and Duncan, 1978]. It was also thought 
that this residue was essential for activity, presumably by interacting with membrane 
cholesterol. However replacement of this residue with Ala in LLO [Michel et al., 1990] 
and in other CDCs [Pinkney et al., 1989; Saunders et al., 1989] did not significantly 
affect activity, although it did remove the sensitivity to oxidation or thiol-alkylation 
agents. Replacement with Gly or bulkier amino acids, however, abolished most of the 
activity, indicating that the mechanism underlying Cys-mediated reversible inhibition of 
cytolytic function probably involves steric hindrance due to formation of toxin dimers or 
heterodimers with other proteins via disulfide bridges.  
 
1.2.4 PEST motif and LLO stability 
     The PEST-like motif is any protein sequence rich in proline, glutamate, serine, and 
threonine residues [Rechisteiner and Rogers, 1996]. PEST-like sequences are thought to 
target eukaryotic proteins for phosphorylation and/or rapid degradation by the 
proteasome. A putative PEST-like motif has been identified close to the N-terminus of 
LLO (highlighted sequence in Figure 1.2.3) and its role in pathogenesis studied [Decatur 
and Portnoy, 2000; Lety et al., 2001].  
     Deletion of the PEST-like motif in L. monocytogenes LLO led to increased 
cytotoxicity and lower virulence. When the sequence was introduced in PFO and the 
chimeric toxin was expressed in L. monocytogenes, bacteria were less cytotoxic than 
those expressing wild-type PFO and were able to replicate intracellularly. These data 
suggest that adoption of a PEST motif in LLO is one strategy to restrict the activity of the 
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toxin to the host cell vacuole, thereby preserving the intracellular niche for bacterial 
proliferation [Decatur and Portnoy, 2000]. It has also been shown that L. monocytogenes 
mutants expressing a PEST-deleted hly allele, although fully hemolytic, are strongly 
impaired in the ability to escape from the phagocytic vacuole. This suggests that the 
PEST motif in LLO may also play a specific role in the disruption of the phagosomal 
membrane, for example, by serving as a ligand for targeting other factors required for its 
efficient disruption to that membrane [Lety et al., 2001]. 
 
1.2.5 Cholesterol: membrane receptor? 
     As do many other bacterial and viral proteins, the CDCs take advantage of a 
distinguishing feature of mammalian membranes, in this case the presence of cholesterol 
[Palmer, 2004; Umashankar et al., 2008]. Among all the different lipids in cell 
membranes, the presence of cholesterol is a distinguishing feature of mammalian cells.  
     It was long thought that cholesterol functioned as a membrane receptor for CDCs. 
This paradigm was established based on two phenomena: (1) pre-incubation of 
cholesterol with the toxins inhibited hemolytic activity [Cowell and Bernheimer, 1978; 
Duncan and Schlegel, 1975; Howard et al., 1953; Shany et al., 1974]; and (2) some CDCs 
could bind directly to cholesterol [Iwamoto et al., 1987; Johnson et al., 1980]. Because of 
its ability to directly bind to cholesterol-containing membranes, PFO has been used as a 
probe for membrane cholesterol [Nakamura et al., 2003; Waheed et al., 2001]. However, 
recent findings have challenged this long-standing paradigm, as not all CDCs require 
cholesterol to bind to the membrane. For example, intermedilysin recognizes and binds 
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the human CD59 protein [Giddings et al., 2004]. However, cholesterol is still required for 
the cytolytic activity of intermedilysin [Giddings et al., 2003]. 
     In liposomal membranes containing only phosphatidylcholine and cholesterol, more 
than 50 mole % cholesterol is required for CDCs such as tetanolysin (Alving et al., 1979), 
SLO (Rosenqvist et al., 1980), and PFO (Heuck et al., 2000; Ohno-Iwashita et al., 1992), 
to bind and create a pore in the bilayer. This is an amount of cholesterol well above what 
is stable in model membrane systems. Interestingly, it has been shown that the transition 
from little or no binding to full binding to liposomes occurs in a narrow range of 
cholesterol concentration [Heuck et al., 2000; Rottem, et al., 1982], indicating a function 
of cholesterol more complex than a simple membrane receptor of CDCs. 
 
      
 
     Cholesterol-rich micro-domains in eukaryotic cell membranes are termed lipid rafts. 
Lipid rafts are dynamic assemblies of proteins and lipids that are distinct from the liquid-
disordered bilayer regions of cellular membranes [Simons et al., 2002]. Cholesterol is 
Figure 1.5 (A) Model of membrane bilayer with phospholipids and cholesterol 
molecules; (B) molecular structure of cholesterol. 
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thought to serve as a spacer between the hydrocarbon chains of the sphingolipids and to 
function as a dynamic glue that keeps the raft assembly together [Figure 1.5]. These 
specialized membrane micro-domains compartmentalize cellular processes by serving as 
organizing centers for the assembly of signaling molecules. This in turn influences 
membrane fluidity membrane protein trafficking, and regulates neurotransmission and 
receptor trafficking. The fact that CDCs could go from virtually no binding to maximal 
binding within such a narrow range of cholesterol suggests that they might interact with 
the target membrane via binding to lipid rafts instead of individual cholesterol molecules. 
PFO has been shown to preferentially associate with lipid rafts in cells [Shimada et al., 
2002; Waheed et al., 2001]. The ability to target lipid rafts may enable the bacterial 
pathogen to disrupt essential functions of the cell by disrupting the structure of the lipid 
rafts, a cellular feature where it is increasingly evident that a significant number of 
essential cellular processes, such as signaling and endocytosis, occur. 
 
1.2.6 Acidic pH optimum of LLO activity 
     In spite of significant amino acid sequence similarity with the other members of the 
CDC family, LLO possesses unique biological properties that prevent it from being 
cytotoxic when released by L. monocytogenes into the cytosol. One of the characteristics 
of LLO that contributes to that is its acidic pH optimum (~ pH 5.5).  
  By swapping dissimilar residues from a pH-insensitive orthologue, PFO, a single 
residue in D4, Leu461, was found to be responsible for the acidic pH optimum of LLO 
action. Mutation of Leu to Thr (present in PFO) resulted in an almost 10-fold increase in 
the hemolytic activity of LLO at a neutral pH. However, L. monocytogenes synthesizing 
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L461T displayed a 100-fold virulence defect in the mouse listeriosis model. These 
bacteria escaped from acidic phagosomes and initially grew normally in cells and 
engaged in cell-to-cell spread, but they prematurely permeabilized the host membrane 
and killed the cell [Glomski et al., 2002]. These results suggest that the acidic pH 
optimum of LLO results from an adaptive mutation that limits cytolytic activity to acidic 
vesicles and prevents damage to the host. 
     More recently, it was shown that rapid LLO aggregation at slightly alkaline pH is 
responsible for LLO inactivation [Schuerch et al., 2005], while no reduction in hemolytic 
activity was detected for PFO under the same conditions. A structural basis for pH-
dependent aggregation of LLO was proposed, arguing that acidic residues located on the 
α-helices of domain 3 (D3) determine pH sensitivity. In the major conformational change 
of pore-formation, the α-helices of D3 from each monomer transform into a β-hairpin that 
penetrates the target membrane. However, at alkaline pH and at temperatures above 33 
°C, these helices would prematurely unfurl to β-hairpins, leading to the exposure of core 
hydrophobic residues to the aqueous milieu [Schuerch et al., 2005; Nomura et al., 2007]. 
These results suggest that the acidic cytolytic activity of LLO is caused by a pH-
dependent loss of function, and not by pH-dependent activation. 
      
1.2.7 LLO and autophagy 
     It has been recently suggested that host cells may utilize autophagy as a defense 
against intracellular pathogens [Colombo, 2007; Orvedahl and Lavine, 2009; Swanson, 
2006]. Autophagy is a mechanism by which cytoplasmic components, including long-
lived proteins and damaged organelles (peroxisomes, ER, and mitochondria) are 
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enveloped within specialized double-membrane-bound vesicles that deliver their cargo to 
the lysosome for degradation [Mizushima et al., 2002; Levine and Kroemer, 2008]. 
Recent data suggest that autophagy plays an essential role in both acquired [Paludan et 
al., 2005] and innate immune responses. 
     L. monocytogenes has been shown to interact with the host autophagic machinery 
[Rich et al., 2003]. Py et al. (2007) and Birmingham et al. (2007) reported that under 
normal intracellular conditions, L. monocytogenes is targeted by autophagy and that this 
process efficiently limits bacterial growth. Additionally, LLO was found as the bacterial 
agent necessary and sufficient to induce autophagy subsequent to infection by L. 
monocytogenes [Meyer-Morse et al., 2010].  
 
1.3 Broad-range phospholipase C (PC-PLC)     
     In addition to LLO, two phospholipases have been implicated in the virulence process: 
a broad-range phospholipase C (termed as PC-PLC since it exhibits a high rate of 
hydrolysis of that phospholipid) and phosphatidylinositol-specific phospholipase C (PI-
PLC). PC-PLC and PI-PLC, encoded by genes plcB and plcA respectively, also play 
important roles in the escape of L. monocytogenes from vacuoles.  
     PC-PLC is involved in the lysis of the double-membrane vacuoles after cell-to-cell 
spread [Vazquez-Boland et al., 1992]. The mutant lacking PC-PLC activity was found to 
be 20-fold less virulent in mice and was defective in cell-to-cell spread [Smith et al., 
1995]. Interestingly, in some cases of human cell lines, LLO has been shown to be 
dispensible for vacuolar lysis. Under this situation, in the absence of LLO, a critical role 
of PC-PLC in membrane dissolution of primary and secondary vacuoles has been 
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recognized [Portnoy et al., 1988; Marquis et al., 1995; Gründling et al., 2003; Alberti-
Segui et al., 2007].  
 
1.3.1 Folding and activation of PC-PLC 
     PC-PLC is synthesized and secreted as an inactive proenzyme of 33 kDa. The 
proenzyme translocates across the cell membrane after the cleavage of the N-terminal 
signal peptide. The secreted proenzyme accumulates at the membrane-cell wall interface 
[Marquis and Hager, 2000; Snyder and Marquis, 2003]. The compartmentalization and 
activity of PC-PLC is regulated by its propeptide and the proteolytic activity of a 
metalloprotease (Mpl) of L. monocytogenes [Marquis and Hager, 2000; Slepkov et al., 
2010; Brian et al., 2011]. 
     Mpl is a member of the thermolysin family of metalloproteases that contains a Zn2+ 
ion in the active site [Hase and Finkelstein, 1993]. Mpl is also synthesized as a 
proenzyme of 55-kDa, with an N-terminal propeptide of 30 kDa and a catalytic domain 
of 35 kDa [Mengaud et al., 1991a]. Like PC-PLC, Mpl is secreted and is an associated 
virulence factor of L. monocytogenes. The compartmentalization of Mpl is dependent on 
the propeptide. Removal of the propeptide occurs exclusively by intramolecular 
autocatalysis [Bitar et al., 2008] upon a decrease of environmental pH. 
       With the activation of Mpl proteolytic activity, the N-terminal 26-residue propeptide 
of the PC-PLC proenzyme is removed, producing a mature enzyme PC-PLC of 29 kDa, 
as shown in Figure 1.6 [Vazquez-Boland et al., 1992; Geoffroy et al., 1991; Raveneau et 
al., 1992; Poyart et al., 1993; Marquis et al., 1997; O’Neil et al., 2009]. The mature PC-
PLC is then rapidly released into the environment. 
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     The mechanism by which the propeptide inhibits PC-PLC activity is unclear thus far. 
The propeptide could interfere with folding of the catalytic domain or block the entrance 
Figure 1.6 Schematic diagrams of L. monocytogenes PC-PLC sequence. PC-PLC is 
translated as preproenzyme. The inactive proform of PC-PLC encompasses the 
propeptide and the catalytic domain. With the proteolytic cleavage of Mpl, the 
catalytic domain of 27.7 kDa protein is released to across the cell wall. 
Figure 1.7 Schematic representation of the behavior of PC-PLC and Mpl when L. 
monocytogenes is entrapped in a secondary vacuole upon cell-to-cell spread. Pro-PC-
PLC and pro-Mpl remain at the membrane-cell wall interface until a decrease in pH 
triggers Mpl autocatalysis and Mpl-mediated maturation of PC-PLC. The mature 
proteins are then secreted across the cell wall where PC-PLC can hydrolyze membrane 
phospholipids. [Forster et al., 2011] 
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of the active site of PC-PLC. It is noteworthy that even a single residue from the 
propeptide at the N-terminus is sufficient to prevent PC-PLC activity, presumably due to 
the critical role of the first residue Trp in coordinating zinc ions in the enzyme active site 
[Slepkov et al., 2010].  
 
1.3.2 PC-PLC as a phospholipase      
     Phosphatidylcholine hydrolysis, or lecithinase activity, by L. monocytogenes, had been 
recognized as early as 1962 [Fuzi and Pillis, 1962] in egg yolk agar opacification assays. 
Together with hemolytic activity, which is caused by LLO, lecithinase activity was one 
of the two major phenotypes used to identify the pathogen L. monocytogenes.  As a 
lecithinase/phospholipase, PC-PLC catalyzes cleavage at the glycerol side of the 
phosphodiester bond to give diacylglycerol (DAG) and a phosphorylated head group 
(Figure 1.8). 
     In previous studies, PC-PLC, secreted by the L. monocytogenes into the medium, had 
been isolated and purified [Geoffroy et al., 1991; Goldfine et al., 1993]. The purified 
enzyme had activity over a broad spectrum of substrates, including phosphatidylcholine 
(PC), phosphatidylethanolamine (PE), phosphatidylserine (PS), and sphingomyelin (SM), 
but had only minimal activity towards phosphatidylinositol (PI). The order of specificity 
among the substrates had been identified as PC>PE>PS>SM>>PI [Goldfine et al., 1993].  
It was also suggested that PC-PLC was active over a broad pH range, from 5.5 to 8.0 
[Goldfine et al., 1993]. 
 
	   19	  
 
 
1.3.3 Structure of PC-PLC 
     A crystal structure of the L. monocytogenes PC-PLC awaits solution. However, 
homologues to this PC-PLC have been identified in other Gram-positive bacteria, 
including the phospholipase C from Bacillus cereus (PLCBc) which has 38.7% identity 
over 253 amino acids [Johansen et al., 1988; Gilmore et al., 1989] (Figure 1.9) and α-
toxin from Clostridium perfringens (22.4% identity over 223 amino acids) [Titball et al., 
1989; Titball et al., 1999]. L. monocytogenes PC-PLC shares considerable sequence and 
function identity with PLCBc [Titball, 1993]. Therefore, it is likely that PC-PLC has 
similar molecular architecture to PLCBc.  
 
Figure 1.8 Reactions catalyzed by PC-PLC producing diacylglycerol (DAG) and 
phosphorylated head group as products. The red arrow points to the bond to be broken 
by the hydrolysis of phospholipase C. The phospholipid substrates differ in the head 
group (-X) and can be phosphatidylcholine (PC), phosphatidylethanolamine (PE), 
phosphatidylserine (PS). The phosphatidylinositol (PI) head group is also shown, 
although this is not a substrate for the PC-PLC. 
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     Using the online program SWISS-MODEL [Arnold et al., 2006], I generated a 
homology model structure for the L. monocytogenes PC-PLC (Figure 1.10). This suggests 
that the PC-PLC protein, like PLCBc, is a monomeric helical metalloprotein, with three 
Zn2+ ions in the active site [Hough et al., 1989].  
 
Figure 1.9 Sequence alignment of L. monocytogenes PC-PLC and its homologue from 
B. cereus, PLCBc, produced by online program T-coffee [Di Tommaso et al., 2011]. 
“*”: identical; “:”: conserved substitutions; “.”: semi-conserved substitutions.  The 
residues that coordinate Zn2+ ions are highlighted in yellow. Point mutations made in 
my work are lighlighted in red. 
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1.3.4 PC-PLC as a metalloenzyme  
     The high homology of PC-PLC to PLCBc (38.7% sequence identity, Figure 1.9) allows 
many critical residues to be identified. Notably, all the nine amino acids, namely, Trp-1, 
His-14, Asp-55, His-69, His-118, Asp-122, His-128, His-142, and Glu-146 (residues 
highlighted in yellow in Figure 1.10) that bind to the three Zn2+ atoms in PLCBc are found 
in identical positions in L. monocytogenes PC-PLC. This is consistent with PC-PLC as a 
metalloenzyme like PLCBc, whose activity is dependent on the presence of Zn2+ ions 
[Geoffroy et al., 1991]. 
     There are two major roles that the zinc ions play in metalloenzymes: (1) coordination 
with the substrate that renders it more susceptible to nucleophilic attack; and (2) 
coordination with an active site water molecule that facilitates its nucleophilic attack. 
However, little is known about the zinc ions in L. monocytogenes PC-PLC, except that 
the activity of PC-PLC is zinc-dependent [Geoffroy et al., 1991]. 
     From the structure of the metalloenzyme PLCBc, all of the zinc ions are 
pentacoordinate adopting the trigonal-bipyramidal geometry. Crystal structures of PLCBc 
in complex with various ligands have been obtained, and they are shown schematically in 
Figure 1.10 Modeled structure 
of PC-PLC based on sequence 
homology to PLCBc. Three zinc 
ions are shown in grey spheres. 
All the nine residues coordinated 
with zinc ions are represented in 
yellow sticks. 
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Figure 1.11 in comparison [Hansen et al., 1992, 1993a]. A structure exists with PLCBc 
bound with an inorganic phosphate (Pi) at the active site; Pi is a weak competitive 
inhibitor of the enzyme (50% of inhibition of the enzyme at 50 mM [Hansen et al., 
1992]). Another structure shows the enzyme with a phosphonate inhibitor, 3(S), 4-
dihexanoylbutyl-1-phosphonylcholine, bound; this inhibitor has a Ki of 1.15 mM [Hansen 
et al., 1993a]. Interactions of the inhibitor with the protein provide crucial information for 
the catalytic mechanism. 
 
 
1.3.5 General base/general acid catalytic mechanism – a lesson from PLCBc 
     There is not much consensus on the detailed catalytic mechanism of non-specific 
phospholipase C. One of the few commonly accepted points is the mechanism uses 
general base/general acid catalysis. A water molecule must be activated by a general base 
so that it can attack the phosphodiester linkage. A general acid then provides a proton to 
the leaving group (DAG) so that it can exit the enzyme active site (Figure 1.12). 
Figure 1.11 Active site of PLCBc with three zinc ions and all the coordinating residues. 
Distances between Zn2+ and residues were found in structure of PLCBc in complex 
with (A) inorganic phosphate [Hansen et al., 1992]; (B) binding of a phosphonate 
inhibitor in the active site [Hansen et al., 1993a]. 
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However, whether a bound Zn2+ contributes to nucleophilic water polarization and which 
of many possible side chains acts as the general base are debated. 
          
    
 
 
1.3.6 Enzymatic characteristics of PC-PLC 
     The mechanistic aspects of metalloenzyme-catalyzed hydrolysis of phospholipids 
have been extensively studied with PLCBc [Hergenrother and Martin, 2000]. However, 
the candidate for the general base in PLC hydrolysis remains to be resolved. Usually, 
with three zinc ions in the active site, any zinc bound water is routinely invoked as the 
nucleophile for zinc peptidases, amidases, and zinc phosphoryl transfer enzymes [Strater 
et al., 1996].  However, in the crystal structure of PLCBc complexed with a phosphonate 
substrate analogous inhibitor, there is no such zinc bound water molecule available in the 
Figure 1.12 General acid/general base mechanism proposed for phospholipid 
hydrolysis catalyzed by PC-PLC. 
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active site as shown in Figure 1.13 [Hansen et al., 1993], which leaves the identity of 
general base a subject of speculation.  
     In the complex structure, both Glu4 and Asp55 are in a position to serve as the general 
base in the PLCBc-catalyzed reaction by activation of W2, an active site water molecule 
(although it should be noted that W2 is fairly far from the phosphorus atom). Between 
them, Asp55 was suggested as a better candidate for the general base, since even the 
analogous mutant D55N resulted in about ~ 4000-fold decrease of enzyme efficiency 
while mutations of Glu4 led to more modest effects [Martin and Hergenrother, 1998], and 
PC hydrolysis was reduced but not abolished [Tan and Roberts, 1998].  However, Asp55 
is also a Zn2+ ligand.          




Figure 1.13 Distances (Å) of selected active site residues of PLCBc from a 
phosphonate substrate analogue inhibitor [Hansen et al., 1993a]. The active site water 
as putative general base is in red box. 
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1.3.7 Choline binding pocket 
     As suggested by characterization of the E4A enzyme [Tan and Roberts, 1998], Glu4 
plays a role in substrate binding, particularly in the binding of the choline head group  
[Martin et al., 2000]. The substrate-binding cleft of PLCBc that accommodates the choline 
head group is lined with residues Glu4, Tyr56, and Phe66 (Figure 1.14). Along with 
Glu4, Tyr56 and Phe66 were also found critical for the specific recognition of choline 
containing substrates [Martin et al., 2000]. Presumably, the carboxyl group on the side 
chain of Glu4 helps neutralize the choline positive charge and Tyr56 and Phe66 provide 
aromatic rings to stabilize the positive charge via π-cation interaction. Systematic 
mutation studies of PLCBc activity on different monomeric substrates diC6PC, diC6PE, 
diC6PS were consistent with that hypothesis [Martin et al., 2000]. Of the three residues, 
Glu4 is most critical for the hydrolysis of PC and PS, the head groups of which contain a 
positive charge. The aromatic properties of Tyr56 and Phe66 were essential for optimal 
catalytic efficiency. Interestingly, the largest changes in the kinetic parameters for the 
mutant enzymes were in kcat, which varied over nearly three orders of magnitude, 
whereas changes in Km varied by less than a factor of ten. Therefore the contributions of 
the choline binding pocket were more than simple substrate recognition. The chemistry 
carried out by the enzyme was significantly impacted. 
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1.3.8 Rate-determining step (RDS) 
     Enzyme catalyzed hydrolysis reactions proceed through the steps of substrate binding, 
hydrolysis, product release, and enzyme rearrangement to the unbound conformation. Of 
particular interest in the PC-PLC catalytic cycle is the identity of the rate-determining 
step (RDS). The rate-determining step may involve substrate binding or product release, 
which is external to the hydrolysis reaction, or the hydrolysis itself, which is internal. 
     Studies on the RDS of PLCBc using various viscosity buffers, wherein the diffusion 
coefficient of the enzyme was different [Martin and Hergenrother, 1999], indicated that 
there was little change in reactivity, and hence a diffusion-controlled process, such as 
substrate binding or product release is not rate limiting in PLCBc catalysis. 
     A hydrolysis reaction involves breaking an O-H bond in the transition state. If the 
chemistry of hydrolysis is the rate-determining step of a reaction, the reaction rates would 
be affected by the contents of D2O in the buffer, as the activation energy is higher for 
breaking a D-O bond compared to an H-O bond. A deuterium isotope effect was indeed 
Figure 1.14 Residues lining the choline-
binding pocket in the structure of PLCBc in 
complex with the substrate mimic inhibitor 
(PDB code: 1P6D). The distances of the 
hydrogen in the trimethylammonium 
moiety to the closest atom of the aligning 
residues (Glu4, Tyr56, and Phe66) are 
labeled in Å. 
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observed in the PLCBc catalyzed reaction [Martin and Hergenrother, 1999], indicating 
proton transfer was involved in the rate-determining step.  
     Most of the structure and mechanism studies were only tested on PLCBc. It is likely 
that PC-PLC chemistry is similar to that of PLCBc. However, it is also possible it has 
some unique properties that help facilitate its function as a virulence factor of an 
intracellular pathogen. 
 
1.4 Phosphatidylinositol-specific phospholipase C (PI-PLC) 
     L. monocytogenes PI-PLC is a 33 kDa polypeptide similar to the PI-PLC from B.  
thuringiensis, B. cereus, and Staphylococcus aureus (around 30% primary sequence 
identity) and eukaryotic PI-PLCs, such as that produced by Trypanosoma brucei 
[Mengaud et al., 1991]. PI-PLC enzymes cleave PI in two discrete steps: (1) an 
intramolecular phosphotransferase reaction that generates DAG and inositol 1,2-(cyclic)-
phosphate, followed by (2) hydrolysis of the cyclic water-soluble intermediate to inositol-
1-phosphate. The chemical reaction is shown in Figure 1.15.  
     The structure of the L. monocytogenes PI-PLC has been solved [Moser et al., 1997]. 
As shown in Figure 1.16, this monomeric protein is an (βα)8-barrel with the active site 
located at the C-terminal side of the β-barrel. The purified PI-PLC is highly specific for 
PI, with a pH optimum that depends on the substrate. For example, with PC solubilized in 
Triton X-100 micelles, the pH profile was broad with a maximum between pH 5.5 and 
6.5; however, the cIP hydrolysis reaction was optimal at pH 7. The observation of acidic 
optimum with micellar substrate suggests that, like LLO, it would be active in acidified 
phagocytic vesicles. No hydrolysis of PC, PS, PE, PI-4-phosphate, or PI-4,5-biphosphate 
	   28	  
was observed with PI-PLC [Goldfine and Knob, 1992]. Unlike other bacterial PI-PLC 
enzymes, the L. monocytogenes PI-PLC is much less efficient at catalyzing the hydrolysis 
of glycosylphosphatidylinositol (GPI)-anchored eukaryotic membrane proteins [Goldfine 
and Knob, 1992; Mengaud et al., 1991; Gandhi et al., 1993]. This would fit with its 






     The detailed role of PI-PLC in L. monocytogenes virulence is still unclear. Studies 
with a plcA deletion mutant revealed only a slight reduction in virulence and in the ability 
Figure 1.16 Crystal structure of PI-PLC 
from L. monocytogenes (PDB code: 
1AOD) with inositol (green) bound in the 
active site. 
Figure 1. 15 Reaction catalyzed by L. monocytogenes PI-PLC. 
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of the bacterium to escape from the primary phagosomes of murine bone marrow 
macrophages [Smith et al., 1995]. The absence of PI-PLC led to only a small defect in 
infection in mouse models (threefold increase in LD50) and the cell-to-cell spread was 
unaffected [Smith et al., 1995; Camilli et al., 1991, 1993]. However, a double mutant 
lacking both PI-PLC and PC-PLC is more than 500-fold less virulent than the wild-type 
strain [Smith et al., 1995; Camilli et al., 1991, 1993]. Overall, it seemed that PI-PLC has 
a minor individual role in virulence, but acts synergistically with PC-PLC and LLO, to 
achieve the most efficient vacuolar escape. 
 
1.5 Issues addressed in the thesis 
     The research reported in this thesis focused on three proteinaceous virulence factors of 
the intracellular bacterial pathogen Listeria monocytogenes: listeriolysin O (LLO), broad-
range phospholipase C (PC-PLC), and phosphatidylinositol-specific phospholipase C (PI-
PLC). All three of the proteins contribute to the successful escape of the bacteria from 
acidifying vacuoles that immediately surround them upon entering the host cells or cell-
to-cell spread. My two major projects concerned LLO and PC-PLC; a third project was a 
collaboration with Dr. Gabe Mitchell from the laboratory of Prof. Daniel Portnoy, 
University of California, Berkeley, on a relatively new function for PI-PLC in L. 
monocytogenes pathogenicity. In this third project, my role has been to supply L. 
monocytogenes PI-PLC (and selected variants with minimal activity) and PC-PLC for 
testing in an in vitro autophagy assay. I also prepared PI-PLC enzymes from other Gram-
positive bacteria. Prior to the work with L. monocytogenes virulence factors, I also 
collaborated with Dr. Chris Pace from the laboratory of Prof. Jianmin Gao, Boston 
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College, on a project in developing a fluorescent assay to probe transmembrane α-helix 
association. However, this thesis will present details only of my two major projects on 
LLO and PC-PLC. 
     (1) The roles of D123 and D4 domains in LLO pore-formation  
     LLO is essential in mediating disruption of vacuole membranes. For an intracellular 
pathogen as L. monocytogenes, failure in the vacuolar escape results in abortive and 
avirulent infection. The current model is that C-terminal domain 4 (D4) recognizes and 
engages the target membrane, where on-membrane oligomerization is prompted by 
hydrogen bonding between residues in domain 3 from each monomer. Once triggered, 
each monomer within the oligomer unfurls the α-helices in domain 3 and transforms them 
into two β-strands. It has been assumed that the sequential and cooperative behaviors of 
domain 3 were initiated by D4 binding cholesterol-enriched membranes. However, I 
found that pores could form without all LLO molecules bearing a D4 domain. I cloned 
and expressed a separate protein containing domains 1, 2, and 3 (D123) and the isolated 
domain 4 (D4) of LLO, aiming to isolate the events in its membrane binding and pore-
formation. D123, even though not membrane-lytic by itself, became hemolytic when 
trace amounts of LLO were present. 
      FRET and FCS assays showed that D123 homooligomerizes but also forms 
heterooligomers with LLO in solution. Flow cytometry, used to investigate protein 
binding to POPC/cholesterol vesicles and to red blood cells, showed that D123 has no 
membrane binding affinity on its own, but becomes membrane-localized with sub-lytic 
amounts of LLO. 
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     My results indicate that the cooperative conformational change that leads to 
membrane insertion and pore formation can occur in some monomers in the absence of 
the D4 anchor. Thus, this change does not use D4 as an intramolecular trigger. This is a 
new and intriguing insight into LLO membrane penetration mechanism. 
     (2) Characterization of metalloenzyme PC-PLC. 
     The gene of L. monocytogenes PC-PLC was obtained from Prof. Helene Marquis, 
Cornell University; the metalloprotein was for the first time, cloned, recombinantly 
expressed, and purified into a homogeneous and active form. The kinetic features and 
mechanism of PC-PLC were systematically studied through my work. While a homology 
structure for the protein could be constructed based on the crystal structure of the B. 
cereus PC-PLC, I showed that there are significant differences in the enzymatic activities 
of these two proteins that are likely important for their pathogenicity. 
     PC-PLC is a metalloenzyme, however, the content and association properties of zinc 
ions has been little characterized. These issues were addressed in my work. The 
dissociation constants of the three zinc ions from PC-PLC were estimated to range 
between	  0.05	  to	  60	  μM.	  However	  estimations	  of	  the	  Kd	  for	  Zn2+	  from	  kinetics	  (with 5 
mM diC6PC as substrate at pH 6.0),	   suggest	  a	  much	  tighter	  binding	  of	  Zn2+,	  perhaps	  suggesting	  a	  cooperative	  binding	  of	  the	  last	  zinc	  ion	  and	  substrate.	   	  	  	  	  	  The enzymatic activity of PC-PLC towards a wide variety of substrates was examined. 
Substrates included long-chain phospholipid (PC, PE, PG, PS, SM) in vesicles (LUVs, 
SUVs) and micelles (Triton X-100), and short-chain PC molecules (diC4PC, diC6PC, 
diC7PC) mono-dispersed in solutions. I found that PC-PLC from L. monocytogenes has 
an acidic pH optimum (5.5~6.5), for all substrates. Some amount of hydrophobicity is 
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needed for the substrate since PC-PLC prefers long-chain lipids over short-chain lipids  - 
a preference due to the improved substrate affinity (Km) instead of turnover rate (kcat). In 
evaluating binding studies of the enzyme to vesicles (using FCS), I show that the 
peripheral membrane association is pH-independent with the presence of 50 µM of Zn2+ 
and that the apparent Kd of PC-PLC to POPC/POPG SUVs was very close to the Km for 
monomeric diC7PC.  
     I also attempted to look for potential synergistic interactions of LLO and PC-PLC in 
their membrane disruption activity. However, under my experiment conditions little to no 
such synergism was found. Specifically, there were little effects in membrane lytic 
activity of LLO from the addition of PC-PLC, and PC-PLC enzymatic activity 
experienced no significant augment with the presence of LLO. 	  	  	  	  	  In	   summary,	   the	   zinc	   coordination	   and	   enzyme	   activity	   of	   PC-­‐PLC	   were	  characterized,	  providing	  knowledge	  for	  the	  community	  to	  better	  analyze	  its	  function	  in	   pathogenicity	   in	   vivo.	   Synergism	   of	   LLO	   and	   PC-­‐PLC	  was	   not	   found,	   suggesting	  they	  have	  independent	  roles	  in	  vacuolar	  escape.	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Chapter 2    Materials and Methods 
2.1 Materials 
     1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC) and 1,2-dioleoyl-sn-
glycero-3-phosphoethanolamine-N-(lissamine rhodamine B sulfonyl) (ammonium salt) 
(DOPE-rhodamine), 1,2-dibutyryl-sn-glycero-3-phosphocholine (diC4PC), 1,2-
dihexanoyl-sn-glycero-3-phosphocholine (diC6PC), 1,2-diheptanoyl-sn-glycero-3-
phosphocholine (diC7PC) and 1,2-dioleoyl-sn-glycero-3-phospho-(1'-rac-glycerol) 
(sodium salt) (DOPG), 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-phospho-L-serine (sodium 
salt) (DOPS), 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine (DOPE) were obtained 
from Avanti Polar Lipids (Alabaster, AL) and used without further purification. Most of 
the phospholipids were purchased as dry powders. n-Dodecylphosphocholine  (DPC) was 
purchased from Affymetrix (Santa Clara, CA). Alexa Fluor 488 (Alexa488) and Alexa 
Fluor 555 (Alexa555) succinimidyl esters and Alexa Fluor 488 C5 maleimide were 
obtained from Molecular Probes (Eugene, OR). Isopropylthio-β-galactoside (IPTG), 
ampicillin, and kanamycin were obtained from American Bioanalytical (Natick, MA). 
Human red blood cells (RBC) were obtained from Research Blood Components (Boston, 
MA). Other chemicals were reagent grade from Sigma-Aldrich (St. Louis, MO) unless 
specifically stated.  
     Escherichia coli strains XL-1 Blue (Stratagene, La Jolla, CA) were used for cloning. 
E. coli strains BL21-AI (Life Technologies, Carlsbad, CA) were used for protein PC-PLC 
expression and strains BL21(DE3)PlysS were used for protein LLO and PI-PLC 
expression. All E. coli strains were grown in Luria-Bertani broth (LB; Fisher, Hampton, 
NH). 
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2.2 Production and fluorescent labeling of recombinant proteins 
2.2.1 Plasmids and gene isolations 
     The pET29a-hly plasmid containing the gene for LLO was a generous gift from 
Professor Daniel A. Portnoy, University of California, Berkeley. The LLO gene in this 
plasmid served as the template for PCR to obtain the coding regions specifically for D123 
and D4; Phusion Hot Start High-Fidelity DNA Polymerase (Fisher Scientific, Pittsburgh, 
PA) was used for the PCR. 
     The gene for the PC-PLC from L. monocytogenes encoded in a pET vector (pET-plcB) 
was obtained from Dr. Helene Marquis, Cornell University. 
     The gene for expression of L. monocytogenes PI-PLC, in the vector pTYB11-plcA, 
was previously generated by Dr. Wei Chen in the Roberts Laboratory [Chen et al., 2009]. 
 
2.2.2 Expression and purification of LLO  
     Overexpression and purification of recombinant protein LLO was done following 
published protocols [Glomski et al., 2002]. Specifically, expressing strains were grown to 
stationary phase and inoculated into 1 L fresh LB media. After 90 min of shaking at 30 
°C, expression was induced by the addition of 1 mM of IPTG and maintained for another 
6 hr. The bacterial suspension was centrifuged and the pellet resuspended in 35 ml cold 
lysis buffer (50 mM sodium phosphate, pH 8.0, 1 M NaCl, 20 mM imidazole, 10 mM 2-
mercaptoethanol, 1 mM PMSF). Cells were lysed by ultrasonication. The lysate was 
centrifuged for 30 min at 17000 g. The supernatant was mixed with 5 ml of Ni-NTA resin 
(QIAGEN, Venlo, Netherlands) equilibrated in lysis buffer. The mixture was mildly 
stirred at 4 °C for 1 hr to ensure protein binding. Afterwards, the resin was packed in a 
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column and unbound protein was washed with lysis buffer until the UV absorbance of the 
eluate reached baseline. The column was then washed with lysis buffer, pH 6.0, 
containing 10% glycerol and 0.1% Tween 20. The desired protein was eluted from the 
column with lysis buffer, pH 6.0, containing 800 mM imidazole. The eluate was dialyzed 
against storage buffer (lysis buffer, pH 6.0, with 1 mM EDTA). This procedure yielded 
~20 mg protein per liter of media. 
     Expression and purification of D123 and D4 are reported in detail in Chapter 3. 
      
2.2.3 Expression and purification of L. monocytogenes PI-PLC 
     pTYB11-plcA was transformed into E. coli strain BL21(DE3)pLysS. The bacteria 
were cultured overnight and inoculated into fresh LB media, until the OD600 reached 0.7. 
Expression of protein PI-PLC was induced with addition of IPTG to the final 
concentration of 0.4 mM. After 6 h of shaking at 20 °C, cells were harvested. The 
bacterial suspension was centrifuged and the cell pellet resuspended in column buffer (20 
mM HEPES, 1 M NaCl, pH 8.5). After cell lysis, the supernatant was applied to a chitin 
resin column (New England Biolab, Ipswich, MA). Nonspecifically bound protein was 
washed off with up to 1 L column buffer. The target protein was eluted after incubation 
of the resin with 50 mM DTT to initiate cleavage of the PI-PLC from the chitin-
containing intein. Excess DTT was removed by dialysis in column buffer containing 2 
mM DTT. All steps were performed at 4 °C. 
2.2.4 Expression and purification of S. aureus PI-PLC 
     A plasmid containing the gene for the S. aureus PI-PLC (PI-PLCSa) was previously 
constructed in the Roberts laboratory [Cheng et al., 2012]. After transformation of the 
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gene into E. coli expression strain BL21(DE3), a single colony was picked from plate for 
overnight culture. The resultant overnight culture was inoculated into 1 L of fresh LB 
media; the cells were incubated at 37 °C until the OD600 reached 0.7~0.8. At that point, 
protein expression was induced with 0.4 mM IPTG. The bacterial suspension was shaken 
at 225 rpm at 30 °C for 6 h later and then harvested. 
     Cells were lysed by ultrasonication, and the supernatant containing PI-PLCSa was 
separated from cell debris by centrifugation. 5 mL of Ni-NTA resin was used for the 
supernatant resulting from 1 L of cell culture. Protein was purified following the 
manufacturer’s suggested batch protocol. The eluate from the resin was dialyzed against 
20 mM Tris, pH 8.3 to remove imidazole. 
     After dialysis, the protein was further purified by anion exchange chromatography 
with Q Sepharose Fast Flow (QFF) resin using an increasing salt gradient from buffer A 
(20 mM Tris, pH 8.0) to buffer B (20 mM Tris, 0.6 M NaCl, pH 8.0). Target protein 
eluted at 10~15 mM NaCl. The three most concentrated fractions (5 mL each) were 
collected and stored at 4 °C until use. 
 
2.2.5 Expression and purification of B. thuringiensis PI-PLC 
     A plasmid containing the gene for the B. thurngiensis PI-PLC (PI-PLCBt), previously 
produced in the Roberts laboratory, was transformed into the same E. coli strain used for 
PI-PLCSa. The expression protocol was the same as that of PI-PLCSa. 
     Cells were lysed with ultrasonication and lysate were centrifuged. Supernatant was 
collected for dialysis in 4 L of buffer 20 mM Tris, pH 8.9. After dialysis, the protein was 
purified first through anion exchange chromatography with QFF resins through an 
	   37	  
increasing salt gradient from buffer A (20 mM Tris, pH 8.0) to buffer B (20 mM Tris, 0.6 
M NaCl, pH 8.0). Target protein eluted at about 0.25 M NaCl. The three most 
concentrated fractions (5 mL each) were collected and stored at 4 °C until use. 
     The pooled fractions of PI-PLCBt were then applied to a hydrophobic column (Phenyl 
Sepharose CL-4B) pre-equilibriated with 20 mM Tris, 1 M NaCl, pH 8.0. After protein 
loading, the column was thoroughly washed until the UV signal no longer decreased. The 
target protein was eluted with decreasing salt gradient (1 M to 0 M added NaCl in 20 mM 
Tris, pH 8.0). The eluted protein was concentrated and stored at 4 °C. 
 
2.2.6 Protein concentration and SDS-PAGE 
     Protein concentration was determined by measuring the absorbance at 280 nm on a 
Nanodrop 2000c UV/Vis spectrometer. Extinction coefficients, εLLO = 75,000 M-1•cm-1, 
εD123 = 43,430 M-1•cm-1, εPIPLC(Sa) = 32,000 M-1•cm-1, εPIPLC(Bt) = 43,000 M-1•cm-1, were 
calculated based on protein sequences with ProtParam in the ExPASy web site. 
     Concentrations of PC-PLC were determined using the BCA assay following the 
manufacturer’s protocol [Smith et al., 1985].  
     The purity of all protein samples in this study were analyzed with 12.5% SDS-PAGE. 
 
2.2.7 Fluorescent labeling of recombinant proteins 
     LLO and D123 were labeled with Alexa Fluor 488- or 555- succinimidyl ester 
(Molecular Probes, Eugene, Oregon) on the N-terminal amine. The manufacturer’s 
protocol was employed in labeling, except that the pH for labeling was pH 7 to 
preferentially react with the N-terminal amine. Protein PC-PLC mutant C143S has only 
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one cysteine at residue 168. Therefore, C143S was fluorescently labeled with the thiol-
reactive dye Alexa Fluor 488 C5 maleimide [Hermanson, G., 1996]. 
 
2.3 Methods 
2.3.1 Circular dichroism (CD) 
     Far UV CD spectra of the proteins, covering the wavelength range 200 ~ 250 nm (1 
nm step size with integration time of 10 s), were recorded at 22 °C with a 2 mm light 
path-length cuvette on an AVIV Circular Dichroism Spectrometer Model 420 
(Biomedical Inc., Lakewood, NJ).  
     Thermal melting data were collected at 222 nm over the temperature range 20 to 100 
°C. The ellipticity data were collected in 2 ° steps after a 90 s equilibration time followed 
by 30 s integration.    
 
2.3.2 Inductively coupled plasma mass spectrometry (ICP-MS) 
     The ICP-MS analysis of Zn content of L. monocytogenes PC-PLC was performed on a 
Perkin-Elmer NexION 300X ICP mass spectrometer (PerkinElmer, Waltham, MA). The 
instrument is located at the University of Massachusetts, Amherst, Department of 
Chemistry, in the Vachet Laboratory. Protein samples were subjected to acid digestion 
with a mixture of nitric acid and hydrogen peroxide. After digestion, samples were 
diluted to 10 mL. Triplicate measurements were made for each sample. Both 63Zn and 
65Zn were measured under kinetic energy discrimination (KED) mode. ICP-MS operating 
conditions were as followed: nebulizer flow rate: 0.95 L/min; rf power: 1600 W; plasma 
Ar flow rate: 18 L/min; dwell time: 50 ms; KED cell gas: 4.6 mL/min.   
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2.3.3 Nuclear magnetic resonance spectroscopy (NMR) 
     Specific activity of PC-PLC or PI-PLC towards lipid substrates in the form of 
monomer, micelle, or liposomes could be measured using 31P NMR spectra acquired on 
an Agilent Direct Drive 600 MHz spectrometer at 242.9 MHz (Santa Clara, CA). NMR 
parameters for the different phospholipids were based on previous reports. [Zhou et al., 
1997; Qian et al., 1998] At this high field, 31P dipolar relaxation is minimal so there is no 
appreciable NOE; furthermore, relaxation rates for all species are less than 1 s-1 so that 
there was no saturation of substrate or product resonances under standard acquisition 
conditions.  
For the PC-PLC reaction, enzyme and liposomes were incubated for fixed time at 37 
°C, then the reaction was stopped by addition of quenching buffer (2 M Tris, 0.4% g/mL 
SDS, pH 8.0) to one third of the reaction volume and immediate boiling of the sample for 
5 min. PI-PLC reactions were quenched by addition of glacial acetic acid (one third the 
volume of the reaction). In each reaction, the substrates (phospholipids) and the products 
(phosphorylated head groups) of the phospholipases have distinct 31P chemical shifts in 
the NMR spectrum, as shown in Figure 2.1. The relative concentration of each species is 
proportional to the integrated area of its 31P resonance. A comparison of the product peak 
to the substrate one allows us to calculate the rate of conversion from substrate to 
product. All the activity measurements were taken before the conversion reached 10% of 
substrate so that initial rate conditions applied.  
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2.3.4 Fluorescence correlation spectroscopy (FCS) 
     Fluorescence correlation spectroscopy (FCS) uses a fluorescent microscope and optics 
that can detect fluorescence intensity fluctuations in a very small volume (Figure 2.2). 
The typical size of the laser focus is sub-femtoliter (~1 µm3). Therefore, diffusion 
behavior of fluorescent molecules can be monitored down to a single molecule level. 
With the analysis of the cross-correlation curve, important information such as 
concentration and diffusion coefficient of the fluorescent particles can be obtained. The 
diffusion coefficient is related to the size of the particles in the solution. In the 
experiment where protein associates with liposomes, the two particles have drastically 
different sizes.  By monitoring the variation of diffusion coefficient in the solution, we 
Figure 2.1 31P NMR spectrum of the hydrolysis reaction of POPC catalyzed by PC-
PLC. Substrate POPC and product phosphorylcholine are represented in the 
spectrum as peak A and B, respectively. Inorganic phosphate was added as an 
external standard; the Pi is labeled C. The relative ratio of each species could be 
calculated by integrating the area of each peak. 
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     The FCS instrument was a home-built confocal setup based on an IX-70 inverted 
microscope (Olympus) as previously described [Pu et al., 2009a, 2009b]. Experiments 
were carried out at 20 °C with samples in chambered cover glass wells. Prior to use, the 
chambers were coated with 10 mg/mL of BSA and rinsed with reaction buffer with 1 
mg/mL of BSA to prevent protein adhesion to the sides of the wells. Protein samples (250 
µL) were in MES-buffered saline (20 mM MES, 150 mM NaCl, pH 5.5) or HEPES-
buffered saline (20 mM HEPES, 150 mM NaCl, pH 7.4) with 1 mg/mL of BSA. The 
averaged diffusion coefficients, D, of fluorescent species were calculated as described 
previously [Pu et al., 2009a, 2009b]. Specifically, the relationship of the autocorrelation 
or cross-correlation, G (τ), with fraction bound f, is shown in the equation 2.1, where 
<N> is the time-averaged number of protein molecules in the detection volume, τfree and 
Figure 2.2 Analysis of diffusion behavior of fluorescent particles by FCS. (A) Only 
a few particles were observed via the tiny laser focus (~µm3) in FCS device. Red 
particles: fluorescently labeled protein; grey particles: non-fluorescent vesicles. (B) 
Fluorescence intensity fluctuation curve recorded with time. (C) Correlation curve 
derived from fluctuation curve, the width of which is related to the diffusion 
coefficient (D) of the fluorescent particles. 
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τbound are the diffusion times for free and vesicle-bound protein, respectively, and S is the 
ratio of the axial (z) to the radial (x-y) dimension for the effective volume. The diffusion 
time is given by τspecies=ωo2/4Dspecies, where Dspecies is the diffusion coefficient for each 
species (free or bound) and ωo is the radius of the observation volume in the x-y plane. 
The values of S and ωo were determined at the beginning and end of each day of 
experiments using the calibration dye rhodamine 119 with a reported D=280 µm2/s 
[Magde et al., 1974]. 
 
 
2.3.5 Fluorescence resonance energy transfer (FRET) 
     Steady-state fluorescence experiments assessing interactions of LLO and D123 were 
carried out on a Fluorolog-3 Spectrometer (Edison, NJ). Fluorescently-labeled D123 
(D123-Alexa488) serving as the donor was added to phosphate buffer (10 mM sodium 
phosphate, 100 mM sodium chloride), at either pH 5.5 or pH 7.4, to a final concentration 
of 0.2 µM. LLO labeled with a fluorophore acceptor (LLO-Alexa555) was titrated into 
the solution. The fluorescence of donor D123-Alexa488, measured at 515 nm upon 
excitation at 485 nm, decreased as the concentration of acceptor LLO-Alexa555 
increased, indicating FRET between the two labeled proteins. The FRET efficiency was 
evaluated as (ID–IDA)/ID, where ID is the fluorescence of donor in the absence of acceptor, 
and IDA is the fluorescence in the presence of different concentrations of acceptor protein.   
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2.3.6 Trypsin digestion 
     Trypsin digestion was used to investigate the accessibility of the LLO D4 domain 
when it was incubated in solution with or without liposomes. D4 (50 µM) in Tris buffer, 
pH 8.0, in the absence or presence of 20 mM LUVs (lipid/protein ~ 400:1), was mixed 
with trypsin (0.1% mass of D4) and incubated at 22 °C. At different time points (0, 10, 
30, 60, 100 min), 20 µl of each reaction was taken out, and the digestion reaction was 
terminated by addition of 10 µl of SDS gel loading buffer, followed by boiling at 95 °C 
for 10 min. Proteolysis products as a function of time were analyzed by SDS-PAGE 
using 12.5 % gels. 
 
2.3.7 Liposome preparation  
     Dry lipids were dissolved in chloroform and mixed in the desired ratio. Chloroform 
was removed with a rotary evaporator and the resultant film was dried under vacuum 
overnight. The dry lipid films were re-suspended in buffers, producing multilamellar 
vesicles (MLVs). Large unilamellar vesicles (LUVs) were prepared by extrusion of 
MLVs through polycarbonate membranes with 100 nm pores using an Avestin lipid 
extruder (Avestin, Ottawa, ON); the extrusion was repeated more than 30 times to 
generate a fairly homogeneous population of LUVs. Small unilamellar vesicles (SUVs) 
were prepared by ultrasonication of MLVs until solutions became optically clear. This 
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2.3.8 Calcein leakage assay 
     The membrane lytic activity of LLO and its domain D123 was measured with calcein-
containing vesicles. In the experiment, large unilamellar vesicles (LUVs) were made with 
concentrated fluorescent dye calcein (40 mM) in the corresponding buffers. Any free 
calcein in the solution was removed by buffer exchange via gel filtration on an ÄKTA 
FPLC with Hiload 16/60 Sephacryl S-500 HR prep grade column. Calcein is an 
interesting fluorophore that is self-quenched when concentrated in solution. Therefore, 
the calcein encapsulated vesicles had minimal fluorescence. When the membrane 
integrity of the vesicles is disrupted by a membrane lytic agent, such as LLO, the 
entrapped fluorescent dye leaks out into bulk solution. Upon this dilution of the dye, the 
fluorescence is significantly enhanced. The fluorescence increase is a measure of the 
vesicle membrane leakage. The addition of 0.1% Triton X-100 to the vesicle solution is 
used as positive control (the detergent lyses all the vesicles), while the addition of buffer 
serves as negative control. The difference in fluorescence between the positive and 
negative controls is a measure of maximum (total) leakage. The fluorescence observed 
with LLO can then be linked to the amount of total calcein released into solution. LLO, 
D123, or D4 was serially diluted into a solution of 20 mM HEPES/sodium acetate, 150 
mM NaCl, pH 5.5 or pH 7.4 buffer, containing LUVs (100 µM phospholipid) 
encapsulating 40 mM calcein. Fluorescence of the calcein in the samples was monitored 
at 525 nm (excitation at 485 nm) using a SpectraMax M5 Microplate reader (Molecular 
Devices, Sunnyvale, CA). Fractional leakage, measured after 2 h incubation at 22 °C, 
was calculated as (Iprotein – Ibuffer)/(I+TX-100 – Ibuffer), where Ibuffer is the fluorescent intensity 
when the liposomes were mixed with buffer without any added proteins and I+TX-100 is the 
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intensity after the addition of 0.1 % Triton X-100 to the buffer containing calcein loaded 
vesicles. 
 
2.3.9 Hemolytic assay 
     Human red blood cells were washed three times in phosphate buffered saline (PBS, 10 
mM Na2HPO4, 1.8 mM KH2PO4, 137 mM NaCl, 2.7 mM KCl), pH 7.4, and resuspended 
to 2% (v/v) in PBS at pH 7.4 or pH 5.5 (adjusted with HCl). Proteins were diluted to 
various concentrations in the appropriate pH buffer and mixed 1:1 (v/v) with the red 
blood cell solution. Three samples were prepared and monitored for each protein 
concentration. The resulting mixtures were gently shaken and incubated at 37 °C for 1 h, 
followed by centrifugation. Aliquots of the supernatant from each sample were 
transferred to a 96-well plate for absorbance measurement at 545 nm using the 
SpectraMax M5 Microplate reader. The fractional hemolysis was calculated from the 
absorbance as (Aprotein - Abuffer)/(A+TX-100 - Abuffer). PBS buffer at pH 5.5 or pH 7.4 was 
mixed with cells (no LLO or other recombinant protein) to yield Abuffer, and complete 
hemolysis was achieved by the addition of 0.1 % Triton X-100 to the buffer. 
 
2.3.10 Induction of eryptosis (red blood cell apoptosis) 
     Fresh erythrocytes were washed three times in PBS, pH 7.4. Cells were stimulated 
with 5 µM Cu2+ in Ringer buffer as previously described [Lang et al., 2007] for 16 h. 
Phosphatidylserine exposure on the apoptotic cell membrane was assessed through the 
binding of annexin V [van Engeland et al., 1998]. After copper incubation, cells were 
washed in PBS and resuspended in annexin-binding buffer: 10 mM HEPES, 140 mM 
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NaCl, 2.5 mM CaCl2, pH 7.4. The cells were mixed with 3 µl of annexin V, R-
phycoerythrin conjugate (Life Technologies, Grand Island, NY) or D123-Alexa555 at a 
final concentration of 10 nM. The mixtures (cell density ~ 5×106 cells/mL) were 
incubated for 15 min in the dark at room temperature before flow cytometry analysis. 
 
2.3.11 Flow cytometry 
     This technique was used to assess the binding of the recombinant LLO and D123 
proteins to liposomes and to human erythrocytes. In the liposome binding experiment, 
LUVs composed of POPC/cholesterol (2:1) with 0.1 mol% DOPE-rhodamine were 
mixed with Alexa488 labeled proteins. To assess binding to human erythrocytes, the cells 
were resuspended in PBS, pH 5.5, at a concentration of 5×106 cells/mL, and incubated 
with proteins labeled with Alexa488 or Alexa555 for 10 min. Alexa488 was detected 
using the FITC channel (530±15 nm band pass filter), and Alexa555 and rhodamine were 
detected using the PE channel (585±21 nm band pass filter). Flow cytometry experiments 
were carried out on a BD FACSAria cell sorter (BD Biosciences, San Jose, CA). Data 
analysis was performed with Flowjo (Tree Star, Ashland, OR). 
 
2.3.12 Phosphate colorimetric assay for PC-PLC activity 
     PC-PLC activity on monomer-dispersed substrates diC4PC, diC6PC, and diC7PC in 
solution was measured with a phosphate colorimetric assay using slight modifications of 
a published protocol [Hergenrother et al., 1997]. Hydrolysis of the PC substrates yields 
DAG and a phosphomonoester. The addition of alkaline phosphatase converted the 
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phosphomonoester to inorganic phosphate (Pi) and an alcohol. The Pi produced was 
quantified with a malachite green colorimetric assay [Lanzetta et al., 1979]. 
     Reactions (100 µL) were carried out in various buffers: 20 mM of buffering agent 
(MES for pH 5.0, 5.5, 6.0, MOPS for pH 6.5, 7.0, HEPES for pH 7.5, 8.0, 8.5), 150 mM 
NaCl, 0.1 mg/mL bovine serum albumin (BSA), 50 µM ZnSO4, and the desired 
concentration of substrate. The reaction temperature was 37 °C. Buffers were pre-warmed 
for at least 20 min before the reaction was initiated by the addition of PC-PLC. After 5, 
10, 15, 20, 25, 30 min of each reaction, 15 µL of reaction mixture was removed and 
quenched by mixing with 5 µL of quenching buffer (2 M Tris, 0.4% g/mL SDS, pH 8.0) 
and boiling for 10 min. The phosphomonoester was then dephosphorylated by addition of 
40 unit/ml of alkaline phosphatase (APase), producing inorganic phosphate (Pi) 
stoichiometric to the released phosphomonoester. The Pi was then quantified with a 
malenchite green assay, in which the inorganic phosphate forms a strong complex with 
molybdate. [Lanzetta et al., 1979] The complexed Pi was quantified by its absorbance at 
650 nm. The absorbance measurement was carried out in triplicate in the microplate 
reader. 
 
2.3.13 Transmission electronic microscopy (TEM) 
     Before TEM, 1 mM of LUVs with POPC/cholesterol ratio of 2:1 was incubated with 1 
µM of LLO at room temperature for 1 h. 2 µl aliquots of the liposome-LLO suspension 
were taken and attached to glow discharge-treated carbon support films, washed rapidly 
by touching to one 2-µl droplet of distilled water, and stained by touching to a 2-µl 
droplet of negative staining solution (2% phosphotungstic acid, pH adjusted to pH 7.0 by 
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NaOH). Specimens were examined and photographed in a JEOL 200CX transmission 
electron microscope, operated at 200 kV.  
 
 
	  	  	  	  	  	  	  	  	  	  
Figure 2.3 Schematic representation of the phosphate colorimetric assay for 
phospholipase activity. Substrates (various phospholipids with different head 
groups, shown in red) were hydrolyzed to produce diacylglycerol and a 
phosphomonoester (in red). The latter was dephosphorylated by alkaline 
phosphatase (APase) producing inorganic phosphate (Pi) that was complexed with 
ammonium molybdate and malanchite green. The absorbance of the complex at 
650 nm was used to quantify product.  
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Chapter 3    Listeriolysin O and Domains 
      
     This part of my research set out to separate the functional units of LLO and to explore 
their membrane binding and hemolytic activity individually, as well as their interactions 
with the full-length cytolysin LLO. Proteins consisting of domain 1 through 3 (D123) or 
domain 4 (D4) were separately cloned and expressed. D123 is a soluble protein (although 
it aggregates at low concentrations in solution) that does not bind to membranes, although 
it contains the sequence that becomes the pore-forming β-strands. Even though D123 has 
no membrane-lytic activity on its own, D123 could bind to membranes and aid in 
hemolysis by associating with low concentrations of full-length LLO. This shows that not 
all LLO molecules need D4 cholesterol recognition domain to participate in pore 
formation. In contrast to D123, D4 is very hydrophobic and tends to associate with 
interfaces irrespective of the presence of cholesterol. When solubilized in micelles, D4 
adopts a predominantly β-structure conformation likely reflecting its membrane binding 
conformation. 
 
3.1 Protein preparation 
3.1.1 Gene construction 
    The genes coding for D123 and D4 were obtained through polymerase chain reaction 
(PCR) amplification of pET29a-hly using Phusion Hot Start High-Fidelity DNA 
Polymerase. Primers for D123 included 5’-CGTCGCATATGAAGGATGC-3’ (to 
introduce the NdeI site) and 5’- CATCTCGAGTCATGAAGTTGTTTCAA-3’ (XhoI 
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site). The D4 primers were 5’- ATGCCATATGAAAGCTTATACAGATGGAAAA-3’ 
(the NdeI site) and AATGGGATCCTTATTAGTGGTGGTG (the BamHI site). After the 
restrictive digestion, the amplified fragment of gene of D123 was ligated into a pET-28a 
plasmid and that of D4 into a pET-30a plasmid. DNA constructs were sequenced to 
confirm the correct DNA was generated.  
 
3.1.2 D123 and D4 protein expression and purification 
     Recombinant D123 has an N-terminal His6-tag, and D4 has a C-terminal His6-tag (as 
does LLO). D123 was expressed and purified using the protocol for full-length LLO 
[Glomski et al., 2002]. The same expression protocol for D4 led to packaging of the 
protein in inclusion bodies. Inclusion bodies often contain almost exclusively the over-
expressed protein. The protein is thought to aggregate because proper folding of the 
proteins lags behind the super fast translation. Segregation into inclusion bodies could 
also indicate the aggregation of a fairly hydrophobic protein. 
If the target protein in inclusion bodies can be converted into a soluble and native 
form, it would be a relative convenient way to obtain abundant target protein. Therefore 
the D4 protocol was modified to purposely express and purify D4 in inclusion bodies. For 
this, the culture temperature was kept at 37 °C after induction with 1 mM of IPTG, and 
the expression lasted for 4 h. After cell harvest and lysis, the pellet was extensively 
washed with Tris storage buffer (10 mM Tris 150 mM NaCl, pH 8.0), 1 % Triton X-100 
in Tris buffer, and then Tris buffer again. This treatment removed most of the membrane 
components and other proteins from the pellet. The remaining pellet, consisting largely of 
D4, was solubilized with Tris buffer containing 1 mM sodium dodecyl sulfate (SDS). The 
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SDS was partially removed by overnight dialysis at 4 °C against Tris buffer containing 5 
mM DTT. Dialysis to remove all the SDS caused the protein to precipitate. 
D4 was purified (and detergent exchanged) via size-exclusion chromatography using 
Sephadex G-150 pre-equilibrated with Tris storage buffer containing 2 mM 
dodecylphosphocholine (DPC). DPC is a mild non-ionic detergent with a phosphocholine 
head group. The dialyzed D4 was loaded on the column, and fractions containing D4 
were pooled and dialyzed against Tris storage buffer with 5 mM DTT. In contrast to LLO 
and D123, D4 was found to aggregate at low pH (< 6) as assessed by dynamic light 
scattering (data not shown), hence it was stored in 10 mM Tris storage buffer, pH 8.0, 
with 5 mM DTT.  
     An example of the protein purity achievable is shown in Figure 3.1. 
       
     Recombinant LLO, D123, and D4 were purified to over 95% purity as analyzed by 





Figure 3.1 SDS-PAGE analysis of purified 
recombinant proteins LLO (lane 1: 57 kDa), D123 
(lane 2: 44 kDa), and D4 (lane 3: 14 kDa). 
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3.2 Protein characterization 
3.2.1 Circular dichroism 
     A circular dichroism spectrum showed that D123 had a mixture of α- and β-structures 
(Figure 3.2) in 50 mM sodium phosphate buffer, 150 mM NaCl, 5 mM DTT, pH 6.0. 
This balance of secondary structure for D123 is consistent with the crystal structures of 
CDC proteins [Rossjohn et al., 1997; Boudeau et al., 2009; Polehina et al., 2005].  
D4 was initially solubilized in SDS micelles and then exchanged to milder nonionic 
and phospholipid-mimic dodecylphosphocholine (DPC) micelles. In DPC micelles the 
D4 exhibited secondary structure dominated by β-sheets (Figure 3.2), consistent with the 
structure of the D4 domain in other CDCs. In the thermal melting experiment, protein 
was slowly heated up to 100 °C in the CD cuvette, and the ellipticity at 217 nm was 
monitored as function of temperature (Figure 3.3 filled squares). For DPC micelle-
solubilized D4, the transition in secondary structure was quite sharp, indicating an initial 
well-folded structure for the domain. In contrast, in SDS micelles (Figure 3.3 empty 
squares), the CD signal of D4 became less negative tracking the initial part of the thermal 
curve for the domain in DPC micelles. The lack of a cooperative unfolding transition in 
the heating process suggests a different unfolding mechanism for the D4 in SDS micelles, 
where only partial local unfolding of the D4 occurs over the same temperature range. The 
strong anionic detergent SDS often binds to membrane proteins allowing them to stay 
folded (at least until heating to high temperatures). 





3.3 Vesicle and cell membrane binding 
3.3.1 Binding of LLO and domains to LUVs  
     Flow cytometry was utilized to study protein binding to liposomes. In the experiment, 
the liposomes were made with POPC and cholesterol in the molar ratio of 2:1, and were 
fluorescently labeled with 0.1 mol% of 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine-
N-(lissamine rhodamine B sulfonyl). All proteins of interests were labeled with Alexa 
Fluor 488 at the N-terminus. The fluorescence of both dyes, rhodamine (on LUVs) and 
Figure 3.2 CD spectra of D123 
(empty squares) in 50 mM 
phosphate buffer, 150 mM NaCl, 
5 mM DTT, pH 6.0, and D4 
(filled square) in 2 mM DPC 
micelles, 10 mM Tris buffer, 150 
mM NaCl, pH 8.0. 
Figure 3.3 Thermal denaturation 
curve of D4. Fraction of unfolded 
D4 protein (fU) solubilized in 2 
mM DPC micelles (filled square) 
and D4 in 2 mM SDS micelles 
(empty square), with Tris storage 
buffer, as a function of increasing 
temperature. fU at each 
temperature was calculated from 
the CD signal at 217 nm. 
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Alexa Fluor 488 (on protein), could be monitored with flow cytometry via distinct 
channels; these are displayed as the y-axis and x-axis in the plots (Figure 3.4). Panel A 
and B show protein LLO binding to liposomes at pH 5.5 and pH 7.4. This experiment 
shows that LLO bound efficiently to LUVs with 33 mol% cholesterol at both pH 5.5 
(Figure 3.4 A) and pH 7.4 (Figure 3.4 B), as most of the particles, which were rhodamine 
fluorescence positive (y-axis) were also detected as Alexa Fluor 488 positive (x-axis). 
These “double-positive” particles indicated association of proteins with liposomes. In 
each plot (A and B), there are two noticeable distinct particle populations (a and b). The 
maximized fluorescence intensities of each population are summarized in Table 1. From 
the data in the table, we can see the fluorescence intensities of the lipids in the two 
populations are comparable, indicating these vesicles are of similar sizes. However, the 
protein fluorescence and the ratio of protein-to-lipid fluorescence are different, and both 
are higher at pH 5.5 (Table 1), indicating enhanced binding at the acidic pH. It is not 
entirely clear what these two populations of liposomes are, but their detection by the cell 
sorter indicates these particles are probably fairly large size in comparison with normal 
LUVs (100~200 nm). These large particles are likely to be aggregated lipid vesicles of 
two different protein/vesicle populations arising from membrane lysis of LLO, as seen in 
the TEM images of liposomes with LLO (Figure 3.5). 
     In contrast to LLO, D123 does not bind to the vesicles (Figure 3.4 C). However, about 
30% of the D123 could be detected in association with the LUVs when an equal amount 
of unlabeled LLO was added (Figure 3.4 D), suggesting D123 may associate with the 
target membrane through interactions with the full-length protein. 
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   Population	   Percentage	   Peak	  protein	  fluorescence	  (IP)	   Peak	  lipid	  fluorescence	  (IL)	   IP/IL	  pH	  5.5	   a	   40.9	   8619	   3319	   2.6	  
b	   40.8	   12344	   1815	   6.8	  pH	  7.4	   a	   21.8	   4508	   3822	   1.2	  
b	   59.8	   6652	   2210	   3	  
 
Figure 3.4 LLO and D123 binding to 100 µM of POPC/cholesterol (2:1) LUVs 
monitored using flow cytometry. LUVs were mixed with (A) 100 nM LLO-
Alexa488 at pH 5.5, (B) 100 nM LLO-Alexa488 at pH 7.4, (C) 50 nM D123-
Alexa488 at pH 5.5, and (D) 50 nM D123-Alexa488 and 50 nM of LLO at pH 5.5. 
Table 1. Population percentage and peak fluorescence of particle species a, b in LLO 
binding to POPC/cholesterol (2:1) LUVs. 
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3.3.2 Binding of LLO and domains to human red blood cells 
     To test whether the interaction between LLO and D123 on liposomes translates to 
binding to live cells, we explored the binding of LLO and D123 to human red blood cells. 
LLO is known to bind to human red blood cells, causing severe damage to the cells, and 
inducing apoptosis at low (nanomolar or subnanomolar) concentrations [Carrero et al., 
2004]. Induction of apoptosis by LLO is rapid, and occurs through both caspase-
dependent and -independent pathways. I checked the disruption of red blood cells 
induced by incubation with various amount of full-length LLO through the flow 
cytometry light scattering. The results were consistent with the apoptogenic characteristic 
of LLO, as shown in Figure 3.6. With increasing amounts of LLO, from 0.1 to 0.5 nM, a 
second population, indicated by b, is detected; this population is distinct from that of the 
Figure 3.5 TEM images of POPC/Cholesterol (2/1) LUVs after 1 h of incubation with 
LLO (lipid/protein ratio: 1000) in phosphate buffer pH7.4 at room temperature. 
Representative liposome aggregates with significant LLO binding are shown in red 
circles; and the ones with less protein aggregates are in yellow circles. 
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live cells (labeled a), as shown in Figure 3.6 A. The second population of cells, b, 
appeared higher in the side scattering cross-section and lower in the forward scattering, 
indicating diminished size and higher complexity inside the cells - typical features of 
apoptotic cells. The second population increased with clear apoptotic features as the LLO 
concentration increased (from Figure 3.6 B to D). At 0.5 nM, LLO had the most dramatic 
effects on cell morphology while 0.1 nM of LLO caused no detectable change.  
       
       
 
     Protein binding to the red blood cells was investigated via flow cytometry with 
fluorescently labeled proteins. The results are summarized in Figure 3.7. The panel on the 
Figure 3.6 LLO binding leads to apoptosis of human red blood cells. Cell density 
maps of 107/ml human red blood cells after incubation for 15 min at room temperature 
with various amount of LLO: (A) 0 nM; (B) 0.1 nM; (C) 0.2 nM; and (D) 0.5 nM. 
Live cells show (region a) show higher forward scattering than apoptotic cells (region 
b). The pH of the suspended cells was 7.4. 
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left shows the cell density maps of batches of red blood cells incubated with various 
proteins including (A) LLO, (B) D123, (C) LLO and D123. The panel on the right 
displays the mass histograms of the particles chosen from specific cell populations in the 
corresponding cell density map on the left, based on the fluorescent intensity. As 
expected, LLO associated with the cells in a dose dependent fashion (Figure 3.7 A, i). 
Upon incubation with 1 nM LLO, most of the red blood cells were converted to an 
apoptotic population, as shown in the cell density map in (A). With more protein added, 
more protein was bound, as indicated in the histogram (i).  
     In contrast to full-length protein LLO, D123 neither bound to cells (Figure 3.7 B and 
ii) nor caused any noticeable variation in the morphology of the red blood cells, at 
concentrations up to 100 nM. Population a had little to no association with fluorescent 
D123. The histogram showed 0.21% of the cells were fluorescently labeled. However, 
when non-labeled LLO was added at a lower, non-lytic concentration (~0.2 nM) in 
conjunction with D123, the situation was quite different. There was a second, apoptotic 
population, b, in the cell density map (Figure 3.7 C). Furthermore, 24.5% of the cells in 
population b were now fluorescently labeled, indicating association with D123 (Figure 
3.7 iii). One should keep in mind that in this experiment only D123 was labeled with 
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Figure 3.7 D123 binds to human red blood cells only in the presence of full-length LLO. 
Left panel: cell density maps of 107/ml of red blood cells incubated with (A) 1 nM of 
LLO-Alexa Fluor555, (B) 100 nM of D123-Alexa Fluor555, (C) 100 nM of D123-Alexa 
Fluor555 and 0.2 nM of unlabeled LLO in phosphate buffered saline (PBS) pH 7.4. Right 
panel: the correlated fluorescence histogram of the gated cell populations via the PE-
channel when the cells were passing through the cell sorter. The fluorescence of the cell 
population a, b in cell maps A, B, C is summarized in histograms i, ii, and iii, 
respectively. (i) b1 (the black curve) is the fluorescence histogram of cell population b 
gated in A with 1 nM of LLO-Alexa Fluor555; b2 (the grey curve) is the histogram of a 
similar cell population b in a cell map after incubation with 2 nM of LLO-Alexa Fluor555. 
(ii) Fluorescence histogram of population a in B, when cells were incubated only with 100 
nM of D123-Alexa555: only 0.21% of cells in population a had D123 fluorescence. (iii) 
Fluorescence histogram of populations a (black) and b (grey) in C, when cells were 
incubated with 100 nM of D123 as well as 0.2 nM of non-fluorescent LLO: in population 
a, only 0.45% of cells had D123 fluorescence, but in population b, a significant 24.5% of 
cells had D123 fluorescence, indicating D123 binding to the cells with LLO. 
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3.4 Does D123 bind to apoptotic cells? 
     LLO incubation can lead to apoptosis of the cells, and D123 association occurred 
almost exclusively in the apoptotic population of the cells (b in Figure 3.8), rather than 
with healthy cells (a in Figure 3.8). One possible explanation is that D123 is bound to the 
cells only because they are undergoing apoptosis, where a significant portion of the cell 
membrane properties are altered [Demchenko, 2012]. To investigate this possibility, I 
induced apoptosis in human red blood cells (termed ‘erythropsis’) via an approach that 
did not involve LLO. The association of D123 with these apoptotic cells was studied with 
flow cytometry.  
     To induce apoptosis in human red blood cells, we utilized the protocols by Lang et al. 
[2007]. Red blood cells were incubated overnight with 10 µM Cu2+. The development of 
apoptosis in the cells was confirmed by both the cell morphology and the externalization 
of phosphatidylserine (PS) on the cell surface. As shown in Figure 3.8, the red blood cells 
developed a second population, b (Figure 3.8 A, C), whose smaller size was monitored by 
the forward scattering. Staining of the cell preparations with fluorescent annexin V, 
showed that 22.6% of this population was annexin V positive (Figure 3.8 B), indicating 
the migration of PS to the cell surface and the onset of the apoptotic process [van 
Engeland et al., 1998]. However, fluorescent D123 did not bind to these apoptotic cells, 
as shown in Figure 3.8 D; only 2.2% of population b had D123 fluorescence associated 
with it. Therefore we exclude the possibility that D123 binds to apoptotic cells due to 
varied membrane permeability. D123 binds to the cell membranes in a mechanism 
dependent on LLO, but not on apoptosis. 
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3.5 Membrane lytic activity 
3.5.1 Binding of LLO and D123 can enhance hemolysis 
     The membrane lytic activity of LLO and the construct of domains D123 was measured 
with calcein-loaded vesicles. In the experiment, large unilamellar vesicles (LUVs) were 
made with the concentrated fluorescent dye calcein (40 mM) in the corresponding 
buffers. Any exterior calcein was removed by gel filtration. Calcein is an interesting 
fluorophore that is self-quenched when concentrated in solution. Therefore, the calcein 
encapsulated vesicles had minimal fluorescence. When the membrane integrity of the 
vesicles is disrupted by a membrane lytic agent, such as LLO, the entrapped fluorescent 
Figure 3.8 Cu2+ induced apoptotic cells bind annexin V, the R-phycoerythrin conjugate, 
but not D123-Alexa Fluor 555. Cell density maps of 2×106/ml red blood cells labeled 
with (A) annexin V-PE and (C) 100 nM of D123-Alexa 555 after the overnight 
incubation of red blood cells with 10 µM of Cu2+ to induce erythropsis. Live cell and 
apoptotic cell populations were gated in a and b, respectively, for protein detection. 
Plots B and D summarize the fluorescence histograms of the gated cell populations (a, 
b) from A and C, respectively. 	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dye leaks out into bulk solution. Upon this dilution of the dye, the fluorescence is 
significantly enhanced. The fluorescence increase is a measure of the vesicle membrane 
leakage. The addition of 0.1% Triton X-100 to the vesicle solution is used as a positive 
control (the detergent lyses all the vesicles), while the addition of buffer serves as 
negative control. The difference in fluorescence between the positive and negative 
controls is a measure of maximum (total) leakage. The fluorescence observed with LLO 
addition can then be linked to the amount of total calcein released into solution. 
     As a cytolysin, full-length LLO caused leakage of POPC/cholesterol (2:1) LUVs in a 
concentration- and pH-dependent fashion (Figure 3.9). These results were consistent with 
previous studies [Glomski et al., 2002; Schuerch et al., 2005]. LLO exhibited much better 
lytic activity at acidic pH. At pH 5.5, LLO caused significant calcein release, with 50% 
of liposome leakage achieved by adding approximately 100 nM of LLO (lipid/protein 
ratio = 1000). At pH 7.4, a much higher concentration of LLO was required for vesicle 
leakage. At the highest concentration tested (1 µM, lipid/protein ratio = 100), only about 
20% of calcein was released. In contrast, up to 1 µM of D123 did not cause release of the 
LUV-entrapped calcein at either pH 5.5 or 7.4, indicating that the complete absence of 
D4 impairs the pore-formation ability of LLO, presumably by preventing initial binding 
of D123 to vesicles.  
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     Results from the hemolytic assay paralleled those from the vesicle leakage assay. LLO 
exhibited optimal hemolytic activity at pH 5.5 and noticeably lower hemolytic activity at 
pH 7.4 (Figure 3.10 A). Isolated domain D123 had no noticeable hemolytic activity at 
either pH at concentrations up to 0.5 µM (Figure 3.10 B, squares). Intriguingly, even 
though on its own D123 had no hemolytic activity, co-incubation of D123 could 
significantly augment the cell lytic activity of LLO at pH 5.5, the optimal pH for LLO 
pore formation (Figure 3.10 B). The additional D123 boosted the total cell lysis from less 
to 20% (caused by 0.1 nM LLO) to over 80% at pH 5.5. I did notice that there was much 
higher concentration requirement (up to 0.2 µM) for the domain 123 to work in concert 
with sublytic LLO compared to what is required for lysis by full-length LLO. In contrast, 
at pH 7.4, co-incubation of D123 caused inhibition of LLO hemolysis. Specifically, 1 nM 
LLO on its own caused around 20% hemolysis of the red blood cells. When D123 was 
added along with this concentration of full-length LLO, there was a sharp drop in the 
total leakage. The prevention of LLO-induced lysis of the red blood cells suggests that 

















Figure 3.9 Full-length LLO, but 
not D123, induces vesicle 
leakage. Calcein leakage from 
POPC/cholesterol (2:1) LUVs: 
LLO alone at pH 5.5 (●) and 
pH 7.4 (❍); D123 alone at pH 
5.5 (■) and pH 7.4 (❒).  
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These experiments showed that with sublytic amounts of full-length LLO, the 
addition of domain123 dramatically enhanced red blood cell hemolysis. Presumably the 
activity of D123 is enabled by association with full-length protein LLO and by 
participating in pore-formation together with it. From the knowledge of the pore-
formation mechanism proposed for CDCs [Tweten et al., 2001], domain 1 through 3 
physically possesses all the necessary components for membrane penetration, except the 
initial membrane anchor of domain 4. The absence of the membrane-binding segment 
necessitates some full-length protein LLO. A possibility is that clusters of LLO, even in a 
very small fraction, can recruit D123 in a membrane-bound aggregate that can then 
undergo the conformational change to pore-forming oligomers. 
 
   
 
Figure 3.10 Sub-lytic levels of 
LLO facilitate cell lysis by D123. 
Lysis of 5×107/ml human red 
blood cells caused by (A) LLO at 
pH 5.5 (●) and pH 7.4 (❍) or by 
(B) D123 in the presence of 0.3 
nM of LLO at pH 5.5 (●) or 1 nM 
of LLO at pH 7.4 (❍). In (B) the 
effects of D123 alone at pH 5.5 
(■) or at pH 7.4 (❒) are shown.  	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3.6 Protein interactions of LLO and D123 
3.6.1 Fluorescence correlation spectroscopy 
     Both the vesicle and the human red blood cell data show that the presence of a small, 
sublytic amount of LLO enables D123 to bind to a cholesterol-containing membrane 
(Figure 3.4 D and 3.6 iii). This could be the result of a direct interaction of the two 
proteins in solution before interaction with a membrane or it could reflect recruitment of 
D123 by membrane-bound LLO. Of particular interest is whether LLO or D123 
aggregate in solution at the concentrations used in the LUV binding and hemolysis 
assays. The protein aggregation status was examined via fluorescence correlation 
spectroscopy (FCS). This technique monitors the average translational diffusion 
coefficient (D) of the fluorescently labeled proteins. The D values of LLO and D123 in 
aqueous solution were measured to be 3.7×10 -11 and 4.1×10 -11 m2/s, respectively. 
However, the theoretical D values of LLO and D123 were estimated to be 5.9×10 -11 m2/s 
and 7.1×10 -11 m2/s, respectively, using the program HYDROPRO and simulated 
structures of the proteins [Ortega et al., 2011]. For comparison, the B. thuringiensis 
phosphatidylinositol specific phospholipase C is a 34.9 kDa monomer in solution. The D 
for that protein measured by FCS using the same instrument and rhodamine reference is 
5.8±0.5×10 -11 m2/s; the D calculated by HYDROPRO is 6.1 × 10 -11 m2/s, consistent with 
experimental results [Pu et al., 2009]. For LLO and D123, the D values measured in FCS 
are considerably smaller than their theoretical values, indicating that both LLO and D123 
form oligomers in solution at nM concentrations, typically what I used in liposome 
binding and hemolysis assays. Interestingly, if one of the unlabeled proteins was added to 
a nM solution of the other containing a fluorophore, there was no further change in D.  
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This occurred for proteins in both acidic and neutral buffers. This could indicate that the 
two proteins do not mix in solution but more likely indicates that the aggregates are quite 
heterogeneous and the averaged D cannot reflect subtle changes in aggregation state. The 
FCS experiment says LLO and D123 form homooligomers in solution. However, it 
doesn’t address if they can form heterooligomers as well.  
 
3.6.2 Fluorescence resonance energy transfer of LLO and D123 
     Fluorescence resonance energy transfer (FRET) is an excellent technique to explore 
protein-protein interactions. Therefore, I carried out a FRET experiment with labeled 
LLO and labeled D123 to assess their association in solution. As the effect of D123 on 
sublytic LLO hemolysis required much higher concentrations of D123, the donor protein 
was typically 0.2 µM while the accepter was added up to µM. Protein D123 and LLO 
were labeled with Alexa488 and Alexa555, respectively. As shown in Figure 3.11 A, the 
fluorescence intensity of donor D123-Alexa488  (λmax ~520 nm), decreased as the 
acceptor LLO-Alexa555 (λmax ~565 nm), was added into the solution. At submicromolar 
concentrations of protein, the association of D123 with LLO in solution occurred at both 
pH 5.5 and pH 7.4 (Figure 3.11 B). Based what we learned from FCS, that both proteins 
oligomerize by themselves in solution, the association between LLO and D123 
undoubtedly produces hetero-oligomers instead of a simple 1:1 interaction. Therefore it 
was impossible for me to extract a dissociation constant from the plot. However, the 
extent of the FRET signal was smaller at pH 7.4 in comparison with that at pH 5.5, 
suggesting that the heterooligomers formed near neutral pH had either different 
stoichiometries of the two proteins or the spatial relationship of the two fluorophores in 
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the aggregate was different. Nonetheless, this indicates that in solution LLO and D123 
can directly associate at both acidic and physiological pH.  
  
 
3.7 Does D4 binding to micelles and vesicles depend on cholesterol? 
     Expressed and purified domain 4 (D4) had low solubility in the absence of detergent. 
This made binding studies problematic. However, I could assess how the protein behaved 
in comparison to LLO in binding to different interfaces. Initially, the effect of cholesterol 
presented in diC7PC micelles on the intrinsic fluorescence of LLO and D4 was examined. 
As shown in Figure 3.12, there was a 30-40% increase in intrinsic fluorescence of LLO in 
the presence of diC7PC micelles containing cholesterol. This increase in fluorescence 
Figure 3.11 FRET of D123 and LLO 
in solution. (A) Titration of 0.2 µM 
of LLO-Alexa488 in phosphate 
buffer, pH5.5, with D123-Alexa555, 
shows decreased donor (Alexa488) 
intensity and increased acceptor 
(Alexa555) intensity with increasing 
concentration of D123-Alexa555 
(indicated in µM on the figure). (B) 
Calculated FRET efficiency with 
increasing D123 (acceptor) 
concentrations is shown at pH5.5 (●) 
and pH7.4 (❍).  
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likely arises from the Trp-rich loop in D4. This domain of LLO contains four of the total 
five Trp residues in LLO. Changes in the intrinsic fluorescence of the homologous toxin 
perfringolysin O had been used to monitor its interaction with membranes [Nakamura et 
al., 1998]. If D4 alone is specifically activated by cholesterol, D4 interactions with 
diC7PC/cholesterol micelles should yield a similar signal variation. However, when 
recombinant D4 was mixed with diC7PC micelles containing cholesterol, the intrinsic 
fluorescence was the same as with diC7PC alone. In its micelle soluble form (when the 




     D4 binding to large unilameller vesicles (LUVs) with or without cholesterol was also 
investigated, in this cases using susceptibility of the protein to trypsin digestion. The 
digestion products were analyzed with SDS-PAGE, as shown in Figure 3.13. Compared 
with D4 diluted in the solution (lane a in Figure 3.13), which will aggregate and possibly 
misfold as detergent diffuses away leading to rapid proteolysis by trypsin, D4 incubated 
Figure 3.12 Intrinsic 
fluorescence spectra of 1 
µM of recombinant LLO 
(circle) or 2 µM of D4 
(square) mixed with 20 mM 
of diC7PC micelles in the 
absence (filled) and 
presence (empty) of 6 mol% 
of cholesterol. 
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with POPC (b) or POPC/cholesterol (c) small unilamellar vesicles (SUVs) was digested 
much more slowly. Presumably the membrane-anchored portion of D4, when bound is 
protected from the trypsin in the solution. Again, there was no difference between POPC 
and POPC/cholesterol SUV incubations either in the rate of trypsin digestion or in the 
identity of the digestion products (protein fragments were analyzed by LC/MS), 
suggesting that the recombinant D4, in the absence of D123, binds to lipid surfaces in a 




     D4 alone has no lytic activity either on vesicles or on red blood cells (data not shown), 
which is not surprising as it is not the membrane-penetrating domain in the full-length 
protein. Mixing D4 and D123 also did not recover any of the hemolytic ability of LLO. 
Furthermore, binding experiments using flow cytometry showed that D123 was not 
recruited by D4 to the target cell membrane, indicating that when D4 is bound to the 
membrane, it is not able to interact productively with D123.  
Figure 3.13 D4 liposome binding is unchanged by cholesterol. Trypsin digestion of 
D4 in 20 mM Tris, 150 mM NaCl, pH 8.0, monitored by SDS-PAGE: (a) D4 alone, 
(b) D4 incubated with POPC SUVs, and (c) D4 incubated with POPC/cholesterol 
SUVs at different time points (0, 10, 30, 60, 100 min). 
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3.8 Discussion 
     Based on the experimental results, I have suggested a model to account for 
interactions of D123 with LLO (Figure 3.14). D123 and LLO in solution are likely to 
follow an assembly mechanism similar to that of α-hemolysin [Thompson et al., 2011]: 
monomers in the solution constantly associate and dissociate with other monomers or 
small oligomers (i, ii, iii), forming transient complexes. The processes of complex 
association are likely to be reversible until the last step where the conformational 
rearrangement occurs and rapid membrane penetration ensues.  
     In FCS, we observed that both LLO and D123 are multimeric in solution. The 
association between D123 and LLO in solution is likely to be fairly weak but could be 
detected with tenths of µM proteins. FRET experiments showed D123-LLO association 
in the absence of membranes. In the hemolysis assay, D123 oligomers could bind to 
membranes and contribute to hemolysis with the presence of sub-lytic full-length LLO, 
but not isolated D4. However, with sublytic LLO, 1000-fold more D123 than LLO was 
needed to enhance red blood cell hemolysis, indicating that hetero-oligomer formation 
between D123 and LLO was much weaker than homo-oligomer association between 
LLO monomers.  
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     As expected, D123 had no hemolytic activity on its own, since it is devoid of the 
membrane-anchoring domain and therefore the ability to bind membranes. However, 
mixing isolated D4, which could rapidly associate with membranes, with D123 did not 
lead to any membrane lysis. An explanation for this is that the connection loop between 
domain 2 and domain 4 is the lever. Movement of this lever (which should be pH 
sensitive) transmits the signal of membrane binding from D4 to induce the 
conformational change in D123 to form the pore. Flexible linkers have been shown to be 
important for allostery and conformational changes on other proteins (for example see 
[Ma et al., 2011]). When the connection is broken, isolated D123 and D4 cannot recreate 
the function of full length LLO. Therefore, D123 can only enhance hemolysis with full 
length LLO with a potency that is approximately three orders of magnitude lower than 
that of LLO. I propose that the limiting step is the transmission of the membrane-bound 
Figure 3.14 Model of D123 interacting with full-length LLO to cause pore formation. 
D123 monomers in solution reversibly associate with (i) D123, (ii) LLO, and (iii) LLO 
bound on the membrane. LLO binding and insertion to the membrane, both of which 
require a functional domain 4, finally enable D123-LLO complexes to form pores on the 
membrane.  
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LLO conformational change to the LLO-bound D123 monomers on the membrane 
surface, and that this change is triggered and transferred from D4 in full-length LLO. In 
LLO oligomers, the pore-formation signal is directly transduced from D4 in each 
monomer, resulting in a concerted action. For D123-LLO oligomers to work, the signal 
for the conformational change has to come from D4 in the limited number of LLO 
monomers. The ratio of LLO in the complex is unfortunately unclear from our 
experiments, but definitely much less than 1. Although the hetero-oligomers are much 
less effective (presumably because of relatively weak associations), this is the first 
experiment showing that concerted interactions between D123 protein and LLO can lead 
to active pore-formation.   
     Similar to LLO, D123 in concert with sublytic LLO only has membrane lytic activity 
at acidic pH. This is not just the result of decreased binding of the two proteins since 
D123 inhibited the small amount of lysis induced by LLO at neutral pH (Figure 3.9 B). 
This suggests that the conformational rearrangement needed for pore formation has some 
contribution from a titratable group that must be protonated. Schuerch et al. [2005] 
reported the inactivation of LLO aggregates at neutral pH in vitro and hypothesized it 
was due to the partial unfolding of α-helices in D3. It is very likely that D123 maintains 
the same labile fold of full-length LLO at neutral pH. Therefore when D123 is present in 
huge excess in the hemolysis assay, D123 complexed with the small amount of LLO 
leads to aggregated, inactive complexes. 
     My experiments show that D123 and LLO associate in solution, and that the 
complexes form active pores when bound to membranes. The molecular mechanism of 
how D123, without domain 4, cooperates with LLO and works as an active cytolysin is 
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still elusive. In mammalian systems, complex membrane lysins, such as membrane attack 
complex/perforin superfamily (MACPF) have been identified. These lysins consist of 
multiple complement components but they have similar structures and membrane-
disruption mechanisms as CDCs [Hadders et al., 2007; Rosado et al., 2008]. The 
fundamental study of interactions between D123 and LLO may therefore provide insight 
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Chapter 4    PC-PLC 
     Despite a number of studies investigating the contribution to virulence of PC-PLC 
[Vazquez-Boland et al., 1992; Raveneau et al., 1992; Poyart et al., 1993; Marquis et al., 
1995, 1997; Gründling et al., 2003; Alberti-Segui et al., 2007], a specific role for this 
phospholipase in pathogenesis has not been established. There are even fewer studies on 
the enzymatic features and mechanism of the L. monocytogenes PC-PLC [Geoffroy et al, 
1991; Goldfine et al., 1993] in comparison with well-studied homologous enzymes: 
phospholipase C from Bacillus cereus (PLCBc) [Hergenrother and Martin, 2001] and the 
α-toxin of Clostridium perfringens [Titball et al., 1999].  
     In this work, the L. monocytogenes broad-range PC-PLC was cloned, expressed in 
Escherichia coli as an intein-fused recombinant protein, purified and characterized in an 
active and homogeneous form. The zinc content and affinity of the metalloprotein were 
measured. Systematic kinetic studies were employed to probe substrate specificity and 
pH profile. Membrane partitioning of the protein onto POPC/cholesterol vesicles was 
examined by fluorescence correlation spectroscopy (FCS). In addition, mutations of 
residues homologous to active site residues in PLCBc were produced to test a structural 
model generated for L. monocytogenes PC-PLC from the crystal structure of PLCBc. The 
rate-determining step of PC-PLC catalysis was also investigated through assays assessing 
viscosity and deuterium effects. 
 
4.1 Protein preparation and characterization 
4.1.1 Gene construction and protein purification 
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     Plasmid pET29-plcB containing the gene plcB for mature PC-PLC was a generous gift 
from Professor Helene Marquis, Cornell University. The PC-PLC gene was amplified via 
polymerase chain reaction (PCR) using HotStartTaq DNA Polymerase (Qiagen, 
Valencia, CA) and primers 5’-GGTTGCTCTTCCAACTGGTCCG-3’ (to introduce the 
SapI site) and 5’- GCTGCATATGTCAGTGGTGGTGG-3’ (NdeI site). The amplified 
fragment was ligated into the pTYB21 with T4 DNA ligase (New England BioLabs, 
Ipswich, MA). The final gene construct was sequenced by Genewiz (Cambridge, MA). 
After the sequence confirmation, the plasmid was transformed into E. coli expression 
strain BL21-AI (Life Technologies, Grand Island, NY). Protein expression was induced 
with both 0.2% g/mL L-arabinose and 0.4 mM IPTG. Cells were shaken at 225 rpm at 20 
°C for 6 h before harvesting. In this system the recombinant protein was expressed as a 
fusion protein with an N-terminal intein tag. The intein tag contains a chitin-binding 
domain that allows isolation of PC-PLC on a chitin resin. On-resin excision of the intein 
by incubation with dithiothreitol (DTT), following manufacturer’s suggested protocol 
[Chong et al., 1999], yielded purified PC-PLC with its native N-terminus without any 
extra residues from the vector. The PC-PLC protein was precipitated from the solution by 
the addition of 40 % g/g ammonium sulfate powder. After 1 h of mild stirring, the 
precipitated protein was pelleted and re-dissolved in storage buffer (20 mM HEPES, 1 M 
NaCl, 2 mM DTT, pH 8.5) in a volume typically 0.05-0.1 of the original column eluate 
volume. Excessive ammonium sulfate was removed by dialysis against fresh storage 
buffer. Aliquots of purified proteins were stored at 4 °C or frozen with liquid nitrogen in 
20% glycerol and stored in -80 °C. All of the purification procedures were performed at 4 
°C. Site-directed point mutations of PC-PLC were made with the QuikChange Lightning 
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Site-Directed Mutagenesis Kit (Agilent Technologies, Inc., Santa Clara, CA). Mutant 
proteins were expressed and purified following the same protocol as the recombinant 
wild type PC-PLC. The protein concentrations of all samples used in this study were 
measured with a Pierce BCA protein assay kit (Pierce Biotechnology, Rockford, IL) 
[Smith et al., 1985]. 
 
4.1.2 Protein characterization and Zn2+ content 
     The theoretical isoelectric point (pI) of this PC-PLC is 7.37 calculated by ExPASy 
ProtParam tool [Gasteiger et al., 2005]. To prevent protein precipitation over time, a 
basic pH environment (~8.5) was more effective compared to an acidic pH (~6). 
Concentrated salt (1 M NaCl) also improved the long-term stability of PC-PLC. The CD 
spectrum of PC-PLC (Figure 4.1 A) indicated a secondary structure mostly of α-helices 
(~84.3 % as deconvoluted by online program K2D2 [Perez-Iratxeta and Andrade-
Navarro, 2008]). The high helix content is consistent with the crystal structure of PLCBc 
[Hough et al., 1989]. The PC-PLC displayed very similar CD spectrum in the absence (no 
Zn2+ added in the purification) or presence of added Zn2+ (100 µM), suggesting that 
saturating the zinc ion sites did not involve significant alternations in secondary structure 
of the enzyme.  
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4.2 Metalloprotein PC-PLC 
4.2.1 Zinc content 
     Throughout the protein expression and purification procedures, no zinc ions were 
added into protein samples. However, there still is the likelihood that the apo-PC-PLC 
could bind zinc ions from the growth medium or from trace amounts of zinc in water. 
Therefore, ICP-MS was used to measure the concentration of zinc under conditions 
where known concentrations of zinc were purposely added to the protein samples. Protein 
samples were set up in dialysis bags (Figure 4.2) for zinc loading. Two different zinc 
conditions were used, (A) non-zinc buffer (20 mM HEPES, 1 M NaCl, pH 8.0) and (B) 
zinc buffer (5 µM ZnSO4, 20 mM HEPES, 1 M NaCl, pH 8.0). After equilibrium, protein 
Figure 4.1 (A) Circular 
dichoism spectrum of PC-
PLC in 20 mM HEPES buffer, 
150 mM NaCl, pH 8.5; (B) 
Predicted structure of L. 
monocytogenes PC-PLC was 
modeled from structure of 
PLCBc [Hough et al., 1989] 
based on their sequence 
homology by SWISS-
MODEL Alignment Mode. 
Residues that were mutated in 
this study are labeled in color: 
Asp55 (red), His56 (green), 
Phe66 (blue), Cys143 and 
Cys168 (yellow). 
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associated zinc ions increased the total zinc concentration of protein samples compared to 
that of the buffer. The results are summarized in Table 2. 
 
 











Non-Zn2+ buffer 0.040±0.003     
PLC in non-Zn2+ 
buffer 0.040±0.003 1.30±0.02 1.26±0.02 2.97±0.15 0.42 
Zn2+-buffer 5.04±0.06     
PLC in Zn2+-buffer 5.04±0.06 8.73±0.07 3.69±0.07 1.78±0.09 2.08 
 
     In buffer without added Zn2+ (where free Zn2+ was measured at 0.040 µM), the PC-
PLC had an average of 0.4 zinc ions. With 5 µM Zn2+ added, the ratio of Zn2+ to protein 
was 2.1. The number was smaller than the expected three zinc ions per protein from 
PLCBc, reflecting a relatively weaker affinity of the third zinc in L. monocytogenes PC-
PLC. The equilibrium status of PC-PLC associated zinc is schematically represented in 
Figure 4.3. Assuming that the non-Zn2+ sample represents a single ion binding and that 
the 5 µM Zn2+ sample represents some occupation of the third site after the initial two 
sites are filled, the dissociation constants of these two zinc binding can be calculated with 
Figure 4.2 Schematic diagrams of 
ICP-MS samples dialyzed in (A) 
non-zinc buffer; (B) 5 µM Zn2+ 
buffer. After equilibrium, the 
difference of zinc concentrations 
between protein samples (yellow) 
and bulk solution (blue) is the zinc 
bound to protein. 
	   79	  
the equations listed below: the lowest Kd is ~54 nM, the third Zn2+ would have a much 





	  	  	  
	  	  
     For comparison with Zn2+ binding to PC-PLC as measured by ICP-MS, the 
dependence of enzyme activity on added Zn2+ was also measured. The enzyme assays 
were carried out with the monomeric substrate diC6PC (5 mM) at pH 6.0 (chosen because 
optimal activity for this substrate occurred at the acidic pH, vida infra). The relation of 
enzyme specific activity to added zinc concentration is plotted in Figure 4.4. The data 
could be fit well with a hyperbolic function, resulting in an apparent dissociation constant 
(appKd) of zinc from PC-PLC in these reaction conditions of 1.94 ±	   0.22	   μM.	   If	   we	  assume	   that	   all	   three	   zinc	   ions	   are	   needed	   for	   PLC	   activity,	   then	   the	   dissociation	  
Figure 4.3 Schematic representation of multimeric zinc binding to PLC active site. 
And their specific affinities are measured by dissociation constants Kd1, Kd2, and 
Kd3 of the equations. 
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constant	  obtained	  from	  enzyme	  assays	  is	  much	  smaller	  than	  the	  one	  (Kd3	  ~	  60	  μM)	  estimated	   from	   ICP-­‐MS	   analysis	   in	   non-­‐substrate	   containing	   solution.	   It	   could	  suggest	  that	  the	  third	  zinc	  ion	  might	  bind	  to	  active	  site	  cooperatively	  with	  substrate.	  There	  was	  a	  difference	  in	  the	  pH	  of	  the	  ICP-­‐MS	  (pH	  8)	  and	  enzyme	  activity	  (pH	  6)	  studies,	  necessitated	  by	  keeping	  the	  protein	  at	  higher	  concentrations	  in	  solution	  for	  the	   MS	   work.	   However,	   zinc	   binding	   should	   be	   tighter	   at	   the	   more	   basic	   pH	   if	  histidine	  residues	  are	  involved.	  




Figure 4.4 Zinc-dependence of L. 
monocytogenes PC-PLC activity 
towards 5 mM diC6PC in 20 mM 
MES, 150 mM NaCl, 0.1 mg/mL 
BSA, pH 6.0. Data were fitted with 
hyperbolic function (curve) by Origin 
yielding appKd of 1.94 ±	  0.22	  μM. 
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4.3 Substrate specificity  
     The recombinant PC-PLC from L. monocytogenes can catalyze the hydrolysis of a 
range of phospholipid head groups including PC, PE, PS, PG, and sphingomyelin (SM) 
(all presented in Triton X-100 micelles). Of the phospholipids tested, only PI was not a 
substrate. PC is the substrate towards which the enzyme exhibits the highest activity, 
although the activity was fairly robust with PE, PS and sphoingomyelin as well. 
 
     Since PC was the best substrate, and since the aggregation state (monomer, micelle, or 
vesicles) of this phospholipid can be varied by acyl chain length, PC was used as the 
substrate for detailed kinetic studies.  
 
4.4 pH profile  
     The pH profile for PC-PLC is an interesting characteristic, as the synthesis, activation, 
and release of this virulence factor is pH-sensitive [Marquis and Hager, 2000; Yeung et 
al., 2005; Forster et al., 2011]. Phospholipid substrates can be used in various physical 
states (monomer, micelle, or vesicle), which may also affect the pH profile. Towards 
POPC (6 mM) in 20 mM Triton X-100 micelles, PC-PLC exhibited an optimum pH that 
Figure 4.5 Specific activity of PC-
PLC towards 6 mM substrates with 
different head groups 20 mM Triton 
X-100, 20 mM HEPES, 150 mM 
NaCl pH 6, in comparison with PC 
activity (100%). All the glycerol 
lipids used had dioleoyl acyl chains. 
SM was brain sphingomyelin 
(porcine). 
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was acidic – around pH 5 (Figure 4.6, black bars). In comparison, with the same assay 
and substrates, PLCBc exhibited maximal activity at neutral pH (Figure 4.6, grey bars).  
 
     The specific activity of the PC-PLC was also examined towards long chain lipid 
POPC (4 mM) in small unilamellar vesicles (SUVs) in the absence or presence of 
cholesterol (2 mM) (Figure 4.7). In this experiment, cholesterol had no significant effect 
on enzyme activity. As with substrate in micelles, there was a very clear preference of 
PC-PLC for an acidic pH. The optimal pH for activity towards PC SUVs (pH 5) was 
similar to that observed for POPC mixed in Triton X-100 micelles.  
 
Figure 4.6 The pH-dependence of 
specific activity of L. monocytogenes 
PC-PLC (black) and B. cereus PLCBc 
(white) activities towards POPC (6 
mM) in 20 mM Triton X-100 
micelles, 150 mM NaCl, with 0.1 
mg/mL BSA. 
Figure 4.7 PC-PLC specific activity 
towards SUVs as a function of pH. 
Grey bars: 4 mM; white bars: 
POPC /cholesterol (4 mM /2 mM). 
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     More insight into the acidic pH optimum of the enzyme was obtained from the 
detailed kinetic data with the mono-dispersed substrate, diC6PC (Figure 4.8). Over the pH 
range tested (pH 5-8), the turnover rate, kcat, of PC-PLC exhibited a relatively flat 
landscape (Figure 4.8 B), ranging from 4 to 7 s-1. However, Km (Figure 4.8 A), exhibited 
a marked minimum at pH 6 and 6.5. This led to a bell-shaped curve for the overall 
catalytic efficiency kcat/Km (Figure 4.8 C) with an optimal efficiency between pH 6-6.5. 
These results indicate that at least for monomers it is the Km that modulates the enzyme 
efficiency, not the turnover rate. Furthermore, the much lower pH optimum for the PC 
micelle and vesicle systems suggests that this change is modulated by binding of a 
phospholipid in the active site or possibly bulk binding of the protein to the vesicles 
rather than a change in the environment of the catalytic residues. 
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4.5 Micelle effect 
     PC-PLC activity was also examined with substrate diC7PC (Figure 4.9). In the plot of 
activity versus substrate concentration, there are two distinct phases. The transition 
between these was at a diC7PC concentration of 1.75 mM, a value very close to the 
published critical micelle concentration of the pure lipid (1.5 mM [Bian and Roberts, 
1992]). Below that point, there was a hyperbolic increase in activity that followed 
Michaelis-Menten kinetics, from which Km and kcat for monomeric substrate diC7PC 
could be extrapolated. Above that concentration, there was a very steep increase in 
enzyme activity. Thus, as soon as micelles were formed, the PC-PLC specific activity 
Figure 4.8 The pH dependence of 
kinetic parameters for L. 
monocytogenes PC-PLC-catalyzed 
diC6PC hydrolysis: (A) Km, (B) kcat, 
and (C) kcat/Km. All assays were 
conducted in the presence of 50 µM 
ZnSO4. 
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increased and was 3-fold higher than what was observed for monomeric substrate. The 
steepness of the increase indicates that the apparent Km for a micellar phospholipid is 
considerably lower. In other words, the micelle formation from monomer substrates 
enhances enzyme activity. As the catalytic mechanism remains identical, the enhanced 
activity is presumably caused by the micellar interface facilitating substrate binding to 
and/or product leaving the active site. Interestingly, the extent of the rate enhancement is 
comparable to what has been observed for PLCBc [El-Sayed et al., 1985]. 
     
 
 
4.6 Acyl chain specificity 
     With the same head group, substrates with acyl chains of various lengths (diC4PC, 
diC6PC, and diC7PC) were examined. A comparison of Km, kcat, and catalytic efficiency 
(kcat/Km) for the three monomeric short-chain PC substrates is shown in Table 3.  
Enzyme-catalyzed reactions were carried out with each substrate concentration below its 
critical micelle concentration (CMC). Therefore all the substrates should be monomers in 
the reactions. For all three monomers, it is the Km of PC-PLC (which presumably reflects 
Figure 4.9 Specific activity of 
PC-PLC towards diC7PC was 
measured with increasing 
substrate concentrations in 20 
mM MES, 150 mM NaCl, 0.1 
mg/mL BSA, pH 6. Black solid 
curve is the hyperbolic fit of 
monomer diC7PC up to 1.75 
mM; grey dotted curve is the 
hyperthetical hyperbolic fit of 
micelle diC7PC substrates. 
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substrate affinity) that exhibits a strong dependence on acyl chain length. Interestingly, 
the kcat was quite similar for the three different short-chain PC molecules. This suggests 
that at least for monomeric substrate some degree of hydrophobicity is required for an 
isolated phospholipid to bind into the active site.  
 
substrate CMC (mM) a Km (mM) kcat (s-1) b kcat/Km (mM-1 s-1) 
diC4PC 250 43.5±3.4 8.0±0.4 0.18 
diC6PC 14 2.8±0.8 12.8±1.5 4.6 
diC7PC 1.5 0.20±0.05 8.5±0.7 42.5 	  
	  
4.7 Binding of PC-PLC to liposomes 
     For monomer substrate, phospholipid binding, as reflected in Km dictates overall 
enzyme catalytic efficiency over the pH range from 5-8.5. Therefore, it was of interest to 
assess the affinity of PC-PLC for phospholipid vesicles. The interaction of this peripheral 
membrane protein with vesicles was investigated using fluorescence correlation 
spectroscopy (FCS). Under the experimental conditions (POPC was presented in small 
unilamellar vesicles at 20 °C), the activity of PC-PLC towards the vesicles was 
sufficiently low so that less than 5 % (determined by NMR assays) of the total 
phospholipids would be hydrolyzed (assuming sufficient Zn2+ was present) over the time 
required for the FCS measurement. In the absence of added Zn2+ and with the chemical 
Table 3. Kinetic parameters of PC-PLC for substrates of short-chain 
phosphatidylcholine at pH 6. 
a CMC values for the short-chain PC molecules are from Bian and Roberts, 1992. 
b The molecular mass of the protein was 29 kDa, and all assays were conducted in the 
presence of 50 µM ZnSO4. 
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reaction minimized, the association of PC-PLC to the vesicle membranes could be 
measured.  
     For FCS experiment, the protein must be fluorescently labeled. I generated the PC-
PLC mutant C143S, which has a single cysteine (Cys168) available for modification with 
a fluorescent dye. This cysteine was labeled with a thiol-reactive reagent of the dye Alexa 
Fluor 488. Specific activities for C143S were comparable to that of the wild type enzyme 
(Figure 4.11). Thus, neither the mutation nor the labeling should affect the overall 
behavior of the protein. 
     Fluorophore-labeled protein in the solution was titrated with POPC/POPG (95/5) 
SUVs. A small amount of negatively charged lipid POPG was added to help prevent 
fusion of the vesicles. FCS detected and analyzed the fraction of protein bound on the 
vesicles. Measuring this for different PC concentrations could be used to derive the 
apparent dissociation constant (Kd). The final results, shown in Figure 4.10, show the 
effects of two variables: zinc concentration and pH. The apparent Kd at pH 7.4 was 65-85 
µM with no significant change when excess Zn2+ was added. The same apparent Kd was 
observed at pH 5.5 when 50 µM Zn2+ was present. However, at the acidic pH without 
Zn2+, the apparent Kd of the protein for the SUV was 2.5~3-fold higher. Distinct from the 
variation of Km for monomeric substrate with pH, PC-PLC had weaker affinity towards 
PC vesicles at pH 5.5 (in the absence of Zn2+). The addition of 50 µM zinc enhanced the 
affinity of PC-PLC for SUVs at pH 5.5 (the effect of Zn2+ at pH 7.4 was not statistically 
significant). Overall, similar binding of the protein to SUVs at pH 5.5 and 7.4 with 50 
µM zinc indicates that bulk partitioning of the protein on vesicles is not responsible for 
the lower enzymatic activity observed at neutral pH. 
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4.8 Predicted model for PC-PLC and mutation of active site residues 
     The high sequence homology of PC-PLC to the PLCBc allowed me to generate a 
hypothetical structure for the L. monocytogenes enzyme (Figure 4.1 B) based on the 
crystal structures of PLCBc [Hough et al., 1989]. The simulated structure, not 
surprisingly, is very similar to that for PLCBc showing a helical single domain protein. 
Work by Martin and coworkers had explored the relevance of residues in the active site 
to catalytic activity, and in PLCBc the residues Asp55, Tyr56, and Phe66 are part of the 
active site and important for enzymatic activity [Martin and Hergenrother, 1998; Martin 
et al., 2000]. L. monocytogenes PC-PLC conserves the same amino acids at these 
positions with the exception of His56 (which is Tyr in PLCBc).  
     In studies of PLCBc, Asp55 was suggested as the putative general base that aids in 
activating the nucleophilic water for attack on the phosphodiester since alterations at this 
position reduced enzymatic activity 104~106-fold [Martin and Hergenrother, 1998]. In my 
experiment, replacement of Asp55 in PC-PLC with Asn also diminished the enzyme 
Figure 4.10 Apparent dissociation 
constant (Kd) for L. monocytogenes 
PC-PLC binding to POPC/POPG 
(95/5) SUVs at pH 5.5 (20 mM MES) 
or pH 7.4 (20 mM HEPES), with 150 
mM NaCl, and 1 mg/mL BSA. 
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activity. However, the loss of enzymatic activity was not as dramatic as that for the 
Bacillus enzyme (100-fold decrease as shown in Figure 4.11). Nonetheless, this does 
suggest that Asp55 is likely to have a similar role in PLC catalysis where it helps to 
polarize the water molecule that will attack the phosphorus. In the structure of the PLCBc-
inhibitor complex, the choline moiety of the analogous inhibitor could form a cationic 
complex with the π-system of one or both Tyr56 and Phe66 [Hansen	   et	   al.,	   1993a]. 
These two residues were shown to be involved in substrate recognition and enzyme 
specificity [Martin et al., 2000]. In PC-PLC, the activity of mutant H56Y was basically 
comparable to unaltered enzyme, indicating it was a conservative and innocent mutation 
between the two homologous enzymes. However, F66Y, a mutation that might be 
thought of as conservative, caused a dramatic loss of activity. The difference in the 
significance of these two mutations indicated H56 and F66 might not have entirely 
overlapping roles in the two enzymes. In L. monocytogenes mutant F66Y, it is possible 
that the added hydroxyl group may form a hydrogen bond with other active site residues 
so that this residue is no longer aligned for cation-π interactions with the choline.  
 
Figure 4.11 Specific activity of the 
PC-PLC mutants towards 5 mM 
diC6PC in 20 mM MES, 150 mM 
NaCl, 0.1 mg/mL BSA, pH 6. 
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     A unique feature of PC-PLC is that it has two cysteine residues that are absent in the 
PLCBc sequence, Cys143 and Cys168. Both cysteine residues, on the surface of the 
protein, were changed to serine to see if that substitution had any effect on PC-PLC 
activity. C143S actually exhibited higher diC6PC hydrolysis activity than the 
recombinant wild type enzyme, while the activity of C168S was reduced. These results 
suggest that the two free cysteine residues are not essential for catalysis. Neither are they 
critical for disulfide interactions since the protein is a monomer.  
 
4.9 Is there synergism of PC-PLC with LLO in in vitro assays? 
     Since the kinetic results suggest that PC-PLC prefers acidic pH values with bilayers as 
substrates and since LLO is activated upon solution acidification [Glomski et al., 2002; 
Schuerch et al., 2005], I examined the effect of the recombinant PC-PLC on LLO in 
hemolysis of red blood cells and the effect of added LLO on the enzyme activity of PC-
PLC towards POPC/cholesterol (2/1) LUVs. The presence of PC-PLC (up to a maximum 
concentration of 20 nM) had little to no impact on hemolysis caused by LLO (Figure 
4.12). Furthermore, adding LLO to LUVs to disrupt the vesicle structures did not 
dramatically enhance PC hydrolysis by PC-PLC (Figure 4.13), although there was a 
slight improvement in total amount of PC hydrolyzed and perhaps a slightly faster rate 
after the lag phase. At least in these in vitro experiments, there was no significant 
dramatic interplay between the two virulence factors.  
     One should also notice that instead of a linear slope for initial velocity, the reaction 
with substrates in LUVs proceeded through a sigmoidal trajectory (Figure 4.13). This 
curve was unique for substrate presented in LUVs; for substrates in all other conditions 
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(monomer, micelle, or SUV) PC-PLC consistently exhibited an initial rate with a linear 
amount of product formed. The distinct sigmoidal reaction curve of LUVs is likely 
related to the high lateral pressure of vesicles where long chain substrates are ordered 
when packed in a relative flat surface [Traikia et al., 2002]. This type of flat surface 
should be relatively defect-free. In the early stage, the membrane penetration of enzyme 
is infrequent and limited; therefore the initial reaction rate was extremely slow. As the 
reaction proceded, diacylglycerol (DAG), a typical membrane-destabilizing agent, was 
produced and accumulated in the membrane bilayer. Because of its small polar head 
group and large aliphatic acyl chains, DAG increased membrane-packing defects 
[Vamparys, et al., 2013], which accelerated PC-PLC catalyzed reaction. Finally, the 
reaction reached a plateau when DAG built up in the membrane and inhibited the 




Figure 4.12 Hemolytic assay of 
LLO with addition of PC-PLC at 
indicated concentrations. 
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4.10 Catalytic cycle of PC-PLC 
     Enzymatic reactions proceed through a catalytic cycle involving substrate binding, 
reaction, and product release. The rate-determining step (RDS) of PC-PLC catalyzed 
hydrolysis in the catalytic cycle was investigated by the following experiments, which 
investigated viscosity and proton inventory effects on enzymatic efficiency of PC-PLC, 
respectively. 
 
4.10.1 Viscosity effects 
     Hydrolysis by PLCBc was found inhibited by its reaction product diacylglycerol 
(DAG) [Tan and Roberts, 1996]. This suggests the possibility that the reaction rate might 
be limited by the release of the product. If this is the case, solvent viscosity should 
influence the catalytic activity of this non-specific phospholipase. Different sucrose 
viscosities were used to test the effects of solvent microviscosity on PC-PLC activity 
towards diC6PC monomers. The results (Figure 4.14) showed that the activity of L. 
monocytogenes PC-PLC is independent of solvent viscosity. For comparison, the dashed 
Figure 4.13 Time-course of PC-
PLC hydrolysis of 5 mM 
POPC/Cholesterol (2/1) LUVs in 
20 mM MES buffer, 150 mM NaCl, 
pH 5.5, 0.1 mg/mL BSA. LLO was 
added to the final concentration 
indicated for the different curves. 
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line shows the expected relationship of enzyme efficiency for a diffusion-controlled 
reaction. Therefore in the reaction of water-soluble substrate, product release is not the 





4.10.2 Proton inventory effects 
     Solvent isotopic effects on PC-PLC activity were also tested. If proton transfer is 
involved in the rate-limiting step of the reaction, the content of D2O in the solution 
should affect the reaction rate. Indeed, correlation was observed when D2O was added to 
the reaction buffer, and the activity decreased proportionally with increasing D2O mole 
fraction with a slope of -0.47 (R2=0.90). The linear fit also indicates one (instead of 
multiple) proton is transferred during the rate-determining step [Kresge, 1964]. Both the 
solvent viscosity effect and isotopic effects of L. monocytogenes PC-PLC are consistent 
with those for PC-PLCBc [Martin and Hergenrother, 1999], demonstrating the converging 
catalytic features of PC-PLC enzymes and in particular that one proton transfer in the 
Figure 4.14 Plot of relative 
activity as function of relative 
viscosity of the assay solution. 
η is the viscosity of the 
sucrose added solution, ηo is 
the viscosity of the original 
solution, in the absence of 
sucrose. kcat/Km is the activity 
of PC-PLC on diC6PC in the 
solution at pH 6, (Kcat/Km) is 
the activity without sucrose. 
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hydrolysis is rate-limiting. pD values in this study were determined by adding 0.4 to the 





     L. monocytogenes PC-PLC is considered a virulence factor of that microorganism. 
While it has significant sequence homology and a structure that is likely similar to the 
PLC from B. cereus, it does have significant differences in activity and other behavior. 
The purified protein PC-PLC preferred more basic pH and concentrated salt for stability 
in the solution. From circular dichroism its secondary structure exhibited a largely α-
helical content that was not sensitive to the presence of zinc ions. Even though pivotal for 
enzyme activity, zinc ions had little influence over the secondary structure of PC-PLC 
suggesting the protein folds well on its own without Zn2+. 
     Zinc in proteins may be important for structural reasons but when in the active sites of 
metalloenzymes it is crucial for activity [McCall et al., 2000], as is the case for PC-PLC. 
Figure 4.15 Plot of relative 
activity vs mole fraction of 
D2O in the assay solution. n 
is the mole fraction of D2O 
in the solution. kcat/Km is the 
enzymatic efficiency of PC-
PLC towards monomeric 
diC6PC at pH 6 (kcat/Km)° is 
the activity without sucrose. 
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Based on the sequence alignment, the nonspecific PLC enzyme synthesized by L. 
monocytogenes should be similar to PLCBc and the N-terminal domain of α-toxin from C. 
perfringins. Both of them bind three zinc ions in the active site, of which the co-catalytic 
roles of the three zinc ions been well established [Hough et al., 1989; Neylor et al., 1998]. 
ICP-MS analysis in our study suggests that with the presence of 5 µM of zinc, PC-PLC 
contains 2.1 atoms of zinc/molecule. The result was less than the expected three atoms of 
zinc per protein. However, it was not entirely surprising. For both PLCBc and alpha-toxin 
from C. perfringens, prior to the solution of protein structures [Hough et al., 1989; Neylor 
et al., 1998], all assays (atomic absorption spectrometry, EXAFS, EPR, magnetic circular 
dichroism, and ion exchange) showed two zinc ions for each protein instead of three 
[Little and Otnaess, 1975; Little, 1981; Bicknell et al., 1986; Krug and Kent, 1984; 
Nagahama et al., 1997]. This discrepancy indicates that the third metal site might be only 
partially occupied in buffer with 5 µM Zn2+ but without substrate. From my experiment, 
the affinity of the three zinc ions for PC-PLC was estimated to be 54 nM ~ 60 µM when 
no substrate was present. The low affinity of the last zinc ion lends further support to the 
hypothesis that the last zinc is loosely bound in the absence of substrate. More 
importantly, what we see in comparing affinities measured by ICP-MS for Zn2+ binding 
to protein and the Kd extracted from enzymatic studies where monomeric substrate is 
present (at the same pH) strongly suggests that when the protein binds to substrate, 
binding of the third Zn2+ is facilitated.  
     One of the more intriguing kinetic results for this recombinant enzyme is its 
preference for an acidic pH. As a virulence factor PC-PLC is expressed, secreted, and 
activated upon the acidification of the environment [Marquis et al., 1997]. This is a 
	   96	  
marked contrast to the preference of PLCBc for pH > 6. PLCBc maintains high activity at 
pH 8, where the activity of PC-PLC is fairly low. The difference might be expected as the 
two phospholipases are secreted by bacteria of different life styles. L. monocytogenes is 
an intracellular pathogen, whereas B. cereus is not. The PC-PLC, as a virulence factor of 
L. monocytogenes, works in phagosomes/endosomes, where the environmental pH 
progressively drops after vacuole formation. The activity of LLO, the major virulence 
factor of L. monocytogenes, has also been found with profound acidic pH optimum 
[Glomski et al., 2002]. Coordination of the two discrete activities, LLO and PC-PLC, to 
work under the same conditions would be a reasonable strategy to allow the bacterium to 
escape the vacuole and enter the cytosol.  
     Goldfine et al. [1993] reported PC-PLC, isolated from Listeria culture supernatant, 
exhibited a broad pH profile over from pH 5.5-8.0 with micellar substrates. However, it 
should be mentioned that the non-specific phospholipase C activity is sensitive to ions 
that are present in most of biochemical buffers (e.g., phosphate, Tris, acetate, and citrate) 
[Aakre and Little, 1982; Hansen et al., 1992; Hansen et al., 1993b; Goldfine et al., 1993]. 
When the activity was measured in low pHs, the buffering agent acetate might 
compromise the overall activity measured. MES was used to buffer acidic buffers in my 
study; that molecule has little to no effects on PC-PLC activity. 
     The preference of PC-PLC for acidic pH for optimal activity was consistent whether 
substrates were present as monomers, or in micelles vesicles, although it is much more 
pronounced for aggregated substrates. For diC6PC mono-dispersed in solution optimal 
enzyme activity is observed at pH 6.5, where the specific activity is about 3-fold that 
measured at pH 7.5 (Figure 4.8 C). For long chain substrate POPC in either Triton X-100 
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micelles or in SUVs, PC-PLC was most active at pH 5. For the SUVs, the ratio of activity 
at acidic pH to that at neutral pH was as high as 10-fold (Figure 4.7). Nonetheless, the 
active site chemistry catalyzed by the enzyme is the same for all substrates. As observed 
with monomeric diC6PC, kcat exhibited little variation with pH (Figure 4.8 B). The most 
likely explanation for the activity towards vesicles exhibiting a pronounced acidic pH 
optimum lies in the substrate binding as in the case of diC6PC. However, this is not bulk 
partitioning of the enzyme on vesicles (as measured by FCS), which is relatively pH-
insensitive. The apparent Kd values with 50 mM Zn2+ showed little sensitivity to pH and 
had a moderately low value, 65-90 µM. Thus, under POPC vesicle assay conditions, the 
bulk of the protein is at least transiently partitioned onto the vesicle. However, most of 
these initial binding complexes are not catalytically productive when no excess Zn2+ is 
present. Therefore, even when the enzyme is already membrane associated, the successful 
entry of substrate into the enzyme active site from the two-dimensional membrane 
interface might still be challenging, and be affected by altering pH. An example of that 
was seen in a recent study that showed vesicle membrane fusion induced by low pH 
facilitated the enzymatic activity of PLCBc [Shimanouchi et al., 2013]. Of course we 
cannot exclude that when the protein is transiently anchored at a bilayer, product release 
(in this case, release of diacyglycerol into the membrane bilayer [El-Sayed and Roberts, 
1985]) may be facilitated at acidic pH. 
     Even though lipid hydrolysis of PC-PLC occurred at the polar the head group, the acyl 
chain length had considerable effects on PC-PLC activity, at least for monomeric 
substrates. The effect was on Km, the affinity for the substrate, rather than the turnover 
rate (kcat). Similar effects were also found for PLCBc [Little, C., 1977; El-Sayed et al., 
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1985]. This may represent a general way for the phospholipases to engage their 
amphiphilic substrates. Besides the direct contacts with the hydrophilic head group region 
[Hansen et al., 1993a], the potential hydrophobic interaction with the hydrocarbon chain 
of phospholipids from PC-PLC is also important for efficient substrate recognition. The 
micellar effects on PC-PLC activity lend further support for the hypothesis. When 
substrate was packed in aggregates, its diffusion into the enzyme active site was 
facilitated by hydrophobic interaction with enzyme when solvation of the alkyl fatty acids 
was prevented. Such hydrophobic interaction has also been found in the interfacial 
catalysis of phospholipase A2 [Scott et al., 1990]. If one was to design an inhibitor for 
PC-PLC, the moieties extending out of enzyme active site should not be underestimated. 
     Selected mutations introduced into PC-PLC are consistent with a mechanism similar 
to that of PLCBc. Asp55 and Phe66 are two of the most critical residues for PLCBc activity 
[Martin and Hergenrother, 1998; Martin et al., 2000; Hansen et al., 1993a]. They are also 
extremely important for PC-PLC. The two cysteines of PC-PLC seemed to have no 
obvious roles in activity, where mutations did not cause catastrophe in catalysis. 
However, the redox ability of cysteines allows potential in vivo regulation, especially for 
Cys143 because it is close to the active site.  	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Chapter 5    Future Directions 
5.1 Investigation into LLO cysteine glutathionylation 
     The conserved cysteine residue in domain 4 of LLO has been found to be 
glutathionylated in vivo (unpublished results from Portnoy Laboratory, University of 
California at Berkeley). Mutagenesis studies replacing Cys with Ala or Ser consistently 
found it was not essential for either hemolytic activity or virulence in vivo [Michel et al., 
1990]. The fact that this Cys is not critical for CDC activity is interesting, as the Cys is 
preserved in most of the CDC member sequences. Thus, the finding of glutathionylation 
suggests the real function of the Cys has yet to be found.  
     To pursue this investigation, one should first establish the activity of glutathionylated 
LLO. Specifically, one can prepare glutathionylated LLO and test the activity of it in 
vitro through liposome leakage and hemolytic assay. 
 
5.2 Crystallography of PC-PLC 
     Before my work, there was no recombinant L. monocytogenes PC-PLC. Furthermore, 
the purification of the enzyme from cultures of L. monocytogenes provided very little 
protein with modest purity. The expression system I used is capable of generating clean 
and active enzyme, potentially good enough for crystallization trials. One difficulty I 
experienced with this protein was the stability issue upon the addition of zinc. Zinc ions 
are critical for enzyme activity, however, they were no help in terms of stabilizing the 
protein. My hypothesis is that there might be other weak zinc binding sites on the surface 
of the protein and occupation of these sites would disrupt the normal distribution of 
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surface charge and end up destabilizing the protein. Therefore, before any crystallization 
attempts, the PC-PLC needs to be stabilized in the solution with a minimum of zinc.  
     One way to do that is to deliver zinc ions with a moderate metal binder. For example, 
researchers from the Drennan Laboratory at from MIT used a Zn-NTA (nitrilotriacetic 
acid) complex to avoid protein precipitation [Phillips, C. M., et al., 2008]. The complex 
has been tried on PC-PLC in my study. However, the affinity of NTA for zinc (Kd ~ 
3.98×10-11 M [Dawson, R. M. C., et al., 1989]), which was not competitive against with 
the tightly bound Zn2+ in the metalloprotein NikR (Kd < 10-12 M [Wang et al., 2004]) in 
the previous-mentioned study, was an issue for PC-PLC activity. Therefore the proper 
zinc-chelator candidate needs to be identified first. 
     Another issue of current preparation of PC-PLC is the low protein yield. About 1 mg 
of PC-PLC was purified from 1 L of culture media. To make adequate protein for 
crystallography there is a lot of space for improvement.  
     I think an essential issue lies in a tendency of PC-PLC to aggregate in the solution and 
the relatively long time needed for the purification process. Every protein is unique in the 
tendency and extent of misfolding or aggregation. Adding a fusion module could help 
prevent or slow down the aggregation process. The N-terminal intein tag used in current 
protocol is a relatively large (56 kDa) and fairly soluble on its own. There still might be 
better candidate to solubilize PC-PLC. As one example, maltose-binding protein (MBP) 
has been known to increase solubility and prevent aggregation of proteins of interest. 
However, after the affinity chromatography, intein, or any other fusion tag would usually 
be cleaved off PC-PLC. So the aid in solubility from fusion tag will be limited. 
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     Formulation strategies could also be explored to further improve protein stability. In 
my work, salt concentration (1 M or 150 mM NaCl) and pH (pH 6.0 or 8.5) were briefly 
tested. To keep PC-PLC from aggregating, 1 M NaCl at pH 8.5 was optimal. Various 
additives, such as inorganic phosphate or other enzyme inhibitors might be used to help 
maintain PC-PLC in solution.  
     Mutagenesis might be anther approach. For example, the two cysteine mutants C143A 
and C168A exhibited no significant defects in enzymatic behavior in our model systems. 
Potentially a double mutant C143A/C168A could yield a non-thiol protein that has no 
covalent variants (-S-S- bonds). More importantly, the need for reducing agents, which 
can also form complexes with Zn2+, would be abolished.  
     With protocols optimized for protein stability and preparation yield, crystallization of 
PC-PLC could occur with relative ease.  	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